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Acknowledgements
Welcome to the 2015 Severe Maternal 
Morbidity Report from the National Perinatal 
Epidemiology Centre (NPEC). Evaluation 
of severe maternal morbidity (SMM) has 
been acknowledged internationally as an 
important quality indicator of obstetric 
care and maternal welfare, particularly 
in developed countries where maternal 
death rates are relatively low. Further, 
there is evidence that commonly occurring 
life-threatening complications occurring 
during or shortly after pregnancy, such as 
major obstetric haemorrhage (MOH), are 
underexposed as they less frequently lead 
to death in high-resourced countries. In this 
context, the NPEC in collaboration with the 
NPEC Maternal Morbidity Advisory Group, has 
collected and analysed anonymised data 
on SMM data from Irish units since 2011. I 
extend my thanks to the members of the 
Group, listed in Appendix A, for their guidance 
in the continual optimisation of the NPEC 
national clinical audit of severe maternal 
morbidity.
To allow for international comparison, the 
NPEC adapted the validated and respected 
methodology of the Scottish Confidential 
Audit Severe Maternal Morbidity (SCASMM) 
to evaluate SMM in Ireland. This methodology 
utilises organ dysfunction criteria described 
by Mantel et al.1  with modifications used by 
SCASMM to include intervention based criteria.
An integral component of the NPEC SMM 
audit is the detailed assessment of specific 
morbidities to further evaluate maternal 
outcomes and services in Ireland. Topic specific 
case assessment audits are conducted on a 
triennial bases. For the first three years the 
focus was on major obstetric haemorrhage. 
This has provided valuable national data on the 
management of the most commonly occurring 
SMM as detailed in the 2013 SMM Report.  In 
January 2014 the NPEC, in collaboration with 
the SMM Advisory Group, initiated a confidential 
audit on Critical Care in Obstetrics in Ireland. 
The purpose of this audit was to address the 
dearth of national data on the prevalence rates 
for women who require level 2 and level 3 care 
and the location where higher levels of care are 
provided. This audit compliments the Intensive 
Care National Audit and Research Centre 
(ICNARC) audit2 and it gives me great pleasure 
to present the findings for 2015 in Section Two 
of this report. 
Based on the findings in this report a number 
of recommendations for learning and 
improvements have been made. In order to 
ensure that learning is achieved from this and 
other NPEC audit reports, the NPEC aligned 
with the National Office of Clinical Audit (NOCA) 
in 2014. NOCA supports institutions and 
individuals to review and action audit findings 
arising from national clinical audit: effectively it 
aims to close the audit loop, an initiative which 
the NPEC regards as imperative to its mission. 
The NOCA Governance Board endorsement of 
this report is in Appendix B.  
Support from all Irish maternity units is 
instrumental in the success of this national 
audit. On behalf of the NPEC, I extend my sincere 
thanks and appreciation to the many midwives, 
obstetricians and administration staff who 
have voluntarily contributed data to this audit. 
In particular, I gratefully acknowledge the time 
and expertise of designated unit co-ordinators 
(Appendix C) who co-ordinate the collection of 
SMM data at centre level. This report would not 
have been possible without their support.
1 Mantel G et al. Severe Acute maternal morbidity: a pilot study of a definition for a near-miss. BJOG 1998; 105: 985-90.  
2 Intensive Care National Audit and Research Centre (ICNARC) https://www.icnarc.org/
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I would also like to extend my thanks to the 
NPEC Governance Committee, who represent 
a diverse range of key stakeholders from 
maternity centres and universities throughout 
the country, for their support and guidance 
as the Centre continues to grow and evolve 
(Appendix D).
Lastly, I would like to thank the staff of the NPEC 
for their work and dedication to the mission of 
the Centre, by assessing the outcomes of care, 
learning from the data and working with all the 
stakeholders involved, the NPEC continues its 
mission to improve the care of mothers and 
babies in Ireland.
Richard A Greene, Director, NPEC
National Perinatal Epidemiology Centre
5th Floor, Cork University Maternity Hospital
Wilton, Cork, Ireland
Email: npec@ucc.ie
Tel: +353 (21) 420 5017
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Executive summary
This is the fourth report from the national 
audit of severe maternal morbidity (SMM) in 
Ireland. It reports on 381 cases of SMM that 
occurred in 18 of the 19 Irish maternity units 
in 2015. It also reports on findings from the 
first national audit of critical care in obstetrics 
in Ireland. Fifteen of the 19 Irish maternity 
units contributed to the audit of critical care in 
obstetrics in 2015, including two large tertiary 
referral maternity units and thirteen smaller 
maternity units. 
In 2015, the eighteen participating maternity 
units reported that 381 women experienced 
SMM, as defined in this audit, constituting 
a rate of 6.35 per 1,000 maternities. From 
2011 to 2015, the SMM rate varied from 3.83 
to 6.35 per 1,000 maternities or from one in 
260 maternities to one in 157 maternities. 
Respectively, the SMM rate was 16%, 24%, 
55% and 66% higher in 2012, 2013, 2014 and 
2015 than in the base year 2011. Despite this, 
the incidence of SMM in Ireland compares 
favourably with the rate reported from the 
methodologically comparable national audit 
in Scottish maternity units (SCASMM) over 
similar years. The most recently reported 
Scottish SMM rate is 7.3 per 1,000 maternities 
for 2012.
Almost seventy percent of the women (n=263, 
69.0%) who experienced SMM in 2015 were 
diagnosed with one SMM; 25% (n=96, 25.2%) 
were diagnosed with two morbidities; 5% 
(n=18, 4.7%) with three morbidities; and 1% 
(n=4, 1.0%) with four morbidities.
 
In the first three years of the NPEC SMM audit, 
MOH was the most frequently reported SMM 
event. This changed in 2014, when admission 
to an intensive or coronary care unit (ICU/
CCU) was marginally more often reported. 
In 2015, MOH and ICU/CCU admission were 
equally the most frequently reported SMM 
event, both being reported in 47.5% of cases.
Half of the women admitted into an ICU/CCU in 
2015 had not experienced a severe morbidity 
as defined by this audit. This phenomenon 
has increased over the five years of the audit. 
The proportion of cases admitted to an ICU/
CCU with no associated severe morbidity was 
25% in 2011; 35% in 2012; 41% in 2013; 48% in 
2014 and 45% in 2015. Discussions with unit 
personnel suggest such ICU/CCU admissions 
reflect resource issues in maternity units in 
cases where women require a higher level of 
monitoring. Findings from the audit of Critical 
Care in Obstetrics in Ireland in 2015 support 
this suggestion.
The incidence of MOH was 3.02 per 1,000 
maternities in 2015. The equivalent incidence 
of MOH for the most recent year with data 
in Scotland (2012) was 5.8 per 1,000 
maternities, almost twice the Irish rate.
The next most common reportable SMM 
events were renal or liver dysfunction (11.3%), 
septicaemic shock (9.4%), peripartum 
hysterectomy (4.2%) and pulmonary 
embolism (3.9 %). 
There were 43 reported cases involving renal 
or liver dysfunction in 2015. The incidence 
rate of 0.72 per 1,000 maternities was 1.8 
times the rate of 0.41 per 1,000 in 2011-2014.
There were 16 reported cases of peripartum 
hysterectomy (PH) in 2015. The national 
PH rate in Ireland in 2015 is 0.27 per 1,000 
maternities or approximately one in every 
3,750 maternities. This rate is slightly lower 
to national rates reported in the UK and the 
Netherlands of 0.41 and 0.33 per 1,000 births 
respectively.
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There were 36 cases of septic shock reported 
for 2015, this represents an increase on the 
21 cases reported in 2014 and 16 cases in 
2013. These numbers are in contrast with 
the four reported cases in each of the first 
two years of the audit. This may be a true 
increase in incidence or may be associated 
with an increased awareness and recognition 
of sepsis. 
Recent reports on maternal mortality 
in Ireland3 and the UK4 have identified 
thrombosis/thromboembolism as a leading 
direct obstetric cause of maternal death. At 
0.25 per 1,000 maternities or one in 4,616 
women, the incidence of pulmonary embolism 
(PE) in 2015 was the same in 2011-2014. 
Variation in rates of SMM and MOH were 
identified between units. However, differences 
between units must be interpreted with 
caution, as they are likely related to 
differences in the risk profile of the pregnant 
women presenting to the units rather than the 
care given. Variances in rates of MOH between 
units may also reflect variances in practices 
of estimating blood loss.  
For the first time in 2014, nine of the 18 units 
that participated in the SMM audit also provided 
data on all deliveries classified according to 
the Robson Ten Groups Classification System. 
In 2015, nine of the 18 units classified their 
deliveries into one of ten groups, as per the 
Robson Ten Group Classification System. The 
44, 473 deliveries in these units constituted 
over seventy percent (74.1%) of the 60,006 
deliveries in the 18 units that participated 
in the SMM audit. There was evidence of 
increased risk of MOH in Group 8 (women 
with multiple pregnancies) and increased 
risk of other SMM in Group 10 (women with 
premature deliveries).
For the nine units, the MOH rate was 2.7 per 
1,000 deliveries and the rate of other SMM was 
1.9 per 1,000. Notwithstanding the relatively 
small numbers involved when examining 
by Robson Group, there was evidence of 
increased risk of MOH in Group 8 (women with 
multiple pregnancies) and increased risk of 
SMM, excluding the criteria for MOH, in Group 
10 (women with premature deliveries).
The perinatal mortality rate (PMR) among 
infants born to women who experienced SMM 
was 52.2 per 1,000 births, i.e. one in 19 of the 
infants died. This is 7.5 times the perinatal 
mortality rate observed for all births in Ireland. 
However, this rate is similar to findings in 2014 
and is in line with the perinatal mortality rate 
amongst infants born to women with SMM in 
Scotland in recent years, which ranged from 
17 to 64 per 1,000 maternities.
Similar to findings in 2014, multiple pregnancy 
was associated with almost a fourfold 
increased risk of SMM. The SMM rate was 
5.73 per 1,000 maternities associated with 
singleton pregnancy in 2014 and was 19.97 
per 1,000 maternities for multiple pregnancy.
The level of maternal care provided has been 
recorded since the 2014 SMM audit. Virtually 
all of the women who experienced SMM in 
2015 required an increased level of support/
critical care. Almost half required Level 1 Care 
(48.9%), 43.1% required Level 2 Care and 5.8% 
required Level 3 Care.
The audit of critical care in obstetrics showed 
that the incidence of women requiring Level 2 
Care was 7.92 per 1,000 maternities or one in 
126 maternities. For women requiring Level 3 
Care, either solely or in combination with Level 
2 Care, the incidence was 0.43 per 1,000 
maternities or one in 2,307 maternities.
3 O’Hare MF, Manning E, Corcoran P, Greene RA on behalf of MDEIreland. Confidential Maternal Enquiry in Ireland, Data Brief No 2. Cork: MDE 
Ireland, December 2016.
4 Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P, Kurinczuk JJ (Eds.) on behalf of MBRRACEUK. Saving Lives, Improving 
Mothers’ Care - Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland. 
Confidential Enquiries into Maternal Deaths and Morbidity 2012-14. Oxford: National Perinatal Epidemiology Unit, University of Oxford 2016. 
Available at: https://www.npeu.ox.ac.uk/mbrrace-uk
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For the vast majority of women requiring 
Level 2 Care (96.9%) and women requiring 
Level 3 Care (77.8%), the duration of care did 
not exceed four days.
While the location of care for women requiring 
Level 3 Care was primarily in an ICU/CCU 
facility, the location of care for women 
requiring Level 2 Care varied depending on 
the size of the maternity unit. The smaller the 
maternity unit, the greater the utilisation of 
ICU/CCU facilities. This may reflect differences 
in resources between maternity units with 
regard to the availability of obstetric Level 
2 Care and possibly an over utilisation of 
available ICU/CCU facilities.
Advanced respiratory support (n=16, 88.9%) 
and basic cardiovascular support (BCVS) 
(n=15, 83.3%) were the most common organ 
support provided for women requiring Level 3 
Care. For women requiring Level 2 Care, BCVS 
(n=240, 72.9%) and neurological support 
(n=66, 20.1%) were the most common organ 
support provided. 
In women requiring Level 2 Care, hypertensive 
disorders were present in over half (52.3%) of 
the women and nearly thirty percent (28.6%) 
had an obstetric haemorrhage. In those 
requiring Level 3 Care, two thirds had an 
obstetric haemorrhage (n=12, 66.7%). Over 
one in five (22.2%) of the women requiring 
Level 3 Care had a medical disorder which was 
not a direct complication of the pregnancy 
state but was classified as an indirect 
morbidity.
Half of women requiring Level 2 Care did not 
meet the criteria of SMM as defined in the 
NPEC SMM audit and less than one in eight 
met the criteria for the Near Miss (NM) as 
defined by the World Health Organisation 
(WHO). Considering the NPEC SMM and WHO 
NM definitions utilise organ dysfunction 
criteria, it is evident that a number of women 
requiring Level 2 Care do not experience 
organ dysfunction as their clinical needs 
were identified and treated before organ 
dysfunction occurred. This is similar to 
findings of a recent study of HDU admissions 
in a tertiary referral maternity unit in Ireland.
In summary, the findings of this national SMM 
audit highlight the clear need for on-going 
prospective audit in order to identify adverse 
maternal outcomes. Although SMM may reflect 
the complexity of the pregnant population, it 
also acts as a surrogate measure of quality of 
care in the maternity services.
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Recommendations
• Eighteen of the nineteen Irish maternity 
units continue to collate and submit 
data annually to inform the maternity 
services through the NPEC national 
audit on severe maternal morbidity 
(SMM). SMM data from the outstanding 
maternity unit will be available for 
maternities occurring in that unit 
for the calendar year 2016.  Whilst 
this is encouraging, the NPEC would 
like to stress the importance of a 
multidisciplinary approach to ensuring 
complete case ascertainment and 
review of such cases at centre level.
• Alignment of the NPEC in 2014 with 
the National Office of Clinical Audit 
(NOCA) ensures a process by which 
the NPEC can close the audit loop on 
the evaluation of SMM events occurring 
in Ireland. Specifically, maternity units 
that have been identified through 
the NPEC audit to have a statistically 
significant increased rate of SMM 
compared to the national rate are 
required to review quality of audit data 
and clinical practices at centre level.
• Based on 2014 data, the National Office 
of Clinical Audit (NOCA) escalation 
policy has resulted in identified 
outlying units validating SMM data and 
reviewing clinical practices at centre 
level. This has led to changing the 
method used to estimate blood loss in 
one unit, improved case ascertainment 
in another unit, and an on-going review 
process in a third unit.
• Robust clinical audit on adverse 
maternal outcomes requires the 
protected time of clinical staff. Funding 
should be provided by the Health 
Service Executive (HSE) to ensure that 
staffing levels allow protected time for 
clinical audit.
• Formal counselling support should be 
made available for all women and their 
partners following a severe maternal 
morbidity: this is already currently 
available in some units but not all.
• The NPEC endorses the multidisciplinary 
training in the management of 
postpartum haemorrhage advocated 
by the National Clinical Programme 
for Obstetrics and Gynaecology. We 
recommend the development and 
national implementation of a specific 
proforma to improve management and 
documentation during a major obstetric 
haemorrhage event, whether in the 
antenatal or postnatal period.
• A quantitative approach involving 
volume and weight assessment 
to estimate blood loss should be 
considered for use in all maternity 
units. Development of a national tool-kit 
would assist standardisation of such an 
approach.
• The location where critical care for the 
pregnant or recently pregnant woman 
is provided varies across maternity 
units according to available resources: 
Recommendations actioned following the publication of NPEC Severe
Maternal Morbidity report 2014:
Based on the findings of this report, the NPEC makes the following 
recommendations:
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in small units, critical care is often 
provided in the Intensive Care Unit/
Critical Care Unit (ICU/CCU). It is thus 
recommended that in such units, the 
appropriate resources and training 
for the care of the critically ill woman 
in obstetrics are in place within the 
ICU/CCU. For maternity units with 
greater than 2,500 births per annum, 
consideration should be given to 
resourcing the unit with the capacity to 
provide Level 2 Care.
• All pregnant or recently pregnant 
women should have equitable access to 
the most appropriate critical care facility 
for her needs and a national maternal 
retrieval service should be provided. 
This supports the recommendations of 
the National Maternity Strategy.5
• A structured notification system 
between ICU departments and the 
maternity unit responsible for a 
woman’s care during pregnancy 
should be developed to improve inter 
hospital communication. This includes 
communication of an ICU discharge 
summary on pregnant or recently 
pregnant woman (i.e. within 42 days 
of the pregnancy end) who have been 
under the care of an ICU intensivist to 
the relevant maternity unit.
• The World Health Organisation (WHO) 
has endorsed the Robson Ten Group 
Classification System (TGCS) as 
the global standard for assessing, 
monitoring and comparing caesarean 
section rates. However, the use of this 
classification system is not restricted 
to the assessment of caesarean 
section rates but is also a valuable 
methodology tool in auditing adverse 
maternal and perinatal outcomes. At a 
national level, data required to identify 
‘at risk women’ as per the Robson TGCS 
should be collated by all Irish maternity 
units.
5 Department of Health. Creating a Better Future Together: National Maternity Strategy, 2016-2026. Dublin; 2016
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Note: 
On site ICU: Intensive Care Unit on the hospital campus 
General High Dependency Unit: on site hospital campus caring for both obstetric and non-obstetric patients         
Obstetric High Dependency Unit: A HDU in the maternity unit that has the facilities to provide ongoing Level 2 Care for the critically ill woman in obstetrics. 
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Methods
Data recording
There were 20 maternity units in Ireland 
in 2012 and 2013 and 19 maternity units 
from February 2014. Nineteen of the units 
contributed data to this audit for 2012; 20 
units for 2013; and 18 of 19 units contributed 
in 2014 and in 2015. It is expected that data 
will be provided by all maternity centres in 
future audits. The individual contributors 
and co-ordinators for the audit within each 
participating maternity unit are listed in 
Appendix C. These are designated midwives, 
obstetric consultants or specialist registrars 
who complete the NPEC Severe Maternal 
Morbidity Notification Form (Appendix E). This 
is a validated data collection tool originally 
designed for the Scottish Confidential Audit 
of Severe Maternal Morbidity (SCASMM). The 
form was adapted for the Irish setting and 
contains information on maternal and delivery 
characteristics.
In this audit, a case of severe maternal 
morbidity (SMM) was defined as a pregnant 
or recently-pregnant woman (i.e. up to 
42 days following the pregnancy end) 
who experienced any of the following 
seventeen maternal morbidities in 2012-
2015: major obstetric haemorrhage (MOH), 
uterine rupture, peripartum hysterectomy, 
eclampsia, renal or liver dysfunction, 
pulmonary oedema, acute respiratory 
dysfunction, pulmonary embolism, cardiac 
arrest, coma, cerebrovascular event, status 
epilepticus, septicaemic shock, anaesthetic 
complications, admission to an intensive care 
or coronary care unit, interventional radiology 
and other severe morbidity. Definitions for 
these morbidities are provided at the end of 
the notification form (Appendix E).
The other severe morbidity category was 
included to explore whether further specific 
morbidities warrant inclusion in the audit. 
Findings are not provided in this report for 
cases in this category unless one of the other 
specified morbidities was also experienced.
In 2012-2015, uterine rupture was a specified 
morbidity for the audit whereas this was not 
the case in 2011, the first year of the audit. 
This change has led to a small increase in 
reportable cases of SMM. However, most cases 
of uterine rupture meet the criteria for major 
obstetric haemorrhage and were therefore 
reported in all four years of the audit.
Denominator data on the number of 
maternities were provided by the Healthcare 
Pricing Office (HPO).6 The denominator 
underestimates the number of women at risk 
of SMM as it does not include miscarriage, 
ectopic pregnancy and molar pregnancy, 
which may be reported as cases of SMM and 
thereby included in the numerator. However, 
complete data on maternities resulting in 
miscarriage, ectopic pregnancy and molar 
pregnancy are not available and therefore, 
to ensure uniformity, the denominator was 
restricted to live births and stillbirths of 
babies weighing at least 500g.
The approach of not including miscarriage, 
ectopic pregnancy and molar pregnancy in 
the denominator was also the approach taken 
by the Scottish Confidential Audit of Severe 
Maternal Morbidity.
In 2015, nine of the 18 units that participated 
in the SMM audit also provided data on 
deliveries classified according to the Robson 
Ten Group Classification System7 (Appendix 
F). The incidence of MOH and other SMM were 
6 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. 
7 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/
S0965539501000122.
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classified according to Robson Groups for 
these eight units. The deliveries in these units 
constituted three quarters of the deliveries 
in the 18 units that participated in the SMM 
audit.
In January 2014 an audit on Critical Care 
in Obstetrics in Ireland was initiated by the 
NPEC. Levels of care were defined using 
National Guidelines for the Critically Ill Woman 
in Obstetrics (Appendix G).8 Fifteen of the 19 
Irish maternity units contributed to this audit 
in 2015, two large tertiary referral maternity 
units and thirteen smaller maternity units. 
In the case of a woman requiring Level 2 or 
Level 3 Care, participating units were asked 
to complete an additional proforma (Appendix 
H). The main clinical diagnosis, organ support 
required and specialist review during the 
critical care event were identified. Additional 
data on maternal demographics and neonatal 
outcomes were reported on the NPEC SMM 
notification form. 
Maternal morbidity was classified as direct, 
indirect or coincidental based on the main 
clinical diagnosis during the critical care 
event, using the WHO classification for 
maternal mortality (Appendix I).9 Morbidity 
was further categorised using three different 
models for defining maternal morbidity: (a) 
the NPEC SMM methodology which utilises 
organ dysfunction and management based 
criteria, (b) the WHO organ-dysfunction criteria 
defined as Near Miss (NM)10  (Appendix J) and 
(c) the WHO disease specific criteria Severe 
Maternal Complications (SMC) (Appendix K).
Data analysis
In keeping with the international published 
literature in this area, the incidence rate of 
SMM and of specific morbidities are calculated 
per 1,000 maternities resulting in the live 
birth or stillbirth of a baby weighing at least 
500g. For incidence rates, 95% confidence 
intervals were calculated using the Normal 
approximation of a binomial proportion 
confidence interval.
Funnel plots are used to illustrate both 
the variation in incidence rates across 
participating maternity units and the 
deviation of the rate for each individual unit 
from the national rate. 
The national rate is plotted as a straight line. 
The 95% confidence interval for the national 
rate is plotted using dashed lines. The dashed 
lines represent the limits within which 95% 
of units are expected to lie (i.e. within two 
standard deviations). The 99.8% confidence 
interval for the national rate is plotted using 
solid lines. The solid black lines represent 
the limits within which 99.8% of units are 
expected to lie (i.e. within three standard 
deviations). The width of the confidence 
interval is adjusted to allow for meaningful 
comparison between unit-specific rates and 
the national rate. The confidence interval is 
wider for smaller units reflecting the lack of 
precision in rates calculated based on small 
numbers. The confidence interval narrows 
for larger maternity units, giving the diagram 
a ‘funnel’ shape. Maternity unit rates outside 
the 95% and 99.8% confidence interval are 
statistically significantly different from the 
national rate. In general, one in 20 units would 
be expected to lie outside the 95% confidence 
interval by chance alone.
Some of the variation in rates across maternity 
units will be due to differences in the profile 
of the women attending the maternity units. 
Data are not available to allow for adjustment 
of the profile of women attending the 
country’s maternity units. For this reason, 
we recommend conservative interpretation 
of differences between the rates of units and 
their deviation from the national rate.
8 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists,  
Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service Executive
9 The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM. World Health Organisation 2012
10 Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health 
Organization; 2011
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Further analysis was conducted to assess 
variation in incidence rates between years, 
maternal age groups, and single and multiple 
pregnancies. This analysis involved using 
Poisson regression which calculates a rate 
ratio (for example, the rate in one year 
divided by the rate in the previous year). 
Rate ratios have the advantage of being easy 
to interpret. A rate ratio is greater than one if 
a rate is greater than the rate to which it is 
being compared. For example a rate ratio of 
1.25 indicates the rate being examined is 25% 
higher than (or 1.25 times) the rate to which it 
is being compared. Conversely, a rate ratio will 
be less than one if a rate is less than the rate 
to which it is being compared. For example a 
rate ratio of 0.80 indicates that the rate being 
examined is equivalent to 80% of the rate to 
which it is being compared, i.e. it is 20% lower. 
The Poisson regression analysis provides 
a 95% confidence interval for the rate ratio 
and the associated p-value, both of which 
indicate whether the rate difference is in line 
with what might be expected due to chance. 
A rate difference is considered to be beyond 
what might be expected by chance, i.e. 
statistically significant, if the 95% confidence 
interval for the rate ratio does not include the 
value one. This is equivalent to the p-value 
derived from the analysis being less than 
0.05. If the p-value is less than 0.001 then 
the rate difference may be considered highly 
statistically significant.
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Main Findings
The eighteen participating maternity units 
reported that 381 women experienced SMM in 
2015, as defined in this audit. Table 1 details 
the number of cases, total maternities and SMM 
rates derived from the participating units in each 
of the five years of the audit, 2011-2015.
From 2011 to 2015, the SMM rate varied from 
3.83 to 6.35 per 1,000 maternities or from one 
in 260 maternities to one in 157 maternities. 
Respectively, the SMM rate was 16%, 24%, 55% 
and 66% higher in 2012, 2013, 2014 and 2015 
than in the base year 2011. 
A comparable national audit in Scotland for the 
years 2003-2012 reported an SMM rate of 7.3 
per 1,000 maternities for 2012.11 The Irish SMM 
rate in 2015 is 12% lower than the most recent 
Scottish rate (rate ratio=0.88, 95% CI=0.76-
1.01, p-value=0.059).
National rate
Table 1: Incidence of severe maternal morbidity (SMM) in Ireland, 2011-2015
Note: 95% CI=95% confidence interval. Poisson 95% confidence intervals were calculated for the rare ratios. *Cases of uterine rupture exclusive of major 
obstetric haemorrhage were not reported for 2011.
 2011* 2012 2013 2014 2015
Maternities in participating units 67,806 65,768 68,047 61,593 60,006
SMM cases 260 292 323 365 381
SMM rate 3.83 4.44 4.75 5.93 6.35
(95% CI) (3.36-4.31) (3.92-4.96) (4.22-5.27) (5.31-6.54) (5.7-7.0)
Rate ratio 1.00 1.16 1.24 1.55 1.66
(95% CI) (Ref.) (0.98-1.37) (1.05-1.46) (1.32-1.81) (1.41-1.94)
p-value  0.086 0.011 <0.001 <0.001
11 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from: 
http://www.healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx  
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12 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx  
13 Lutomski J et al. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. 
BJOG 2012; 119: 306-14.
Almost seventy percent of the women (n=263, 
69.0%) who experienced SMM in 2015 were 
diagnosed with one SMM; 25% (n=96, 25.2%) 
were diagnosed with two morbidities; 5% 
(n=18, 4.7%) with three morbidities; and 1% 
(n=4, 1.0%) with four morbidities.
In the first three years of the NPEC SMM audit, 
MOH was the most frequently reported SMM 
event. This changed in 2014, when admission 
to an intensive or coronary care unit (ICU/
CCU) was marginally more often reported. 
In 2015, MOH and ICU/CCU admission were 
equally the most frequently reported SMM 
event, both being reported in 47.5% of cases. 
(Table 2).
The incidence of MOH was 3.02 per 1,000 
maternities in 2015. The equivalent incidence 
of MOH for the most recent year with data 
in Scotland (2012) was 5.8 per 1,000 
maternities (95% CI=5.2-6.5), almost twice 
the Irish rate.
The national audit in Scotland showed that 
their increasing incidence of SMM over 
the past decade was due to an increase in 
MOH.12 The NPEC previously showed that 
Ireland experienced an increasing trend in 
postpartum haemorrhage between the years 
1999 to 2009.13
An increasing number of MOH cases has been 
reported to this audit over the five-year period 
2011-2015 (Table 2; Figure 1).
The incidence of MOH cases increased 
from 2.34 per 1,000 maternities in 2011 
to 3.02 per 1,000 maternities in 2015, an 
Table 2: Incidence of specific severe maternal morbidities (SMMs) in Ireland, 2011-2015
 2011-2014 2015
 N(%) Rate(95% CI) N(%) Rate(95% CI)
Major obstetric haemorrhage  670(38.4) 2.63(2.42-2.83) 181(47.5) 3.02(2.57-3.46)
ICU/coronary care unit admission  544(31.2) 2.13(1.95-2.32) 181(47.5) 3.02(2.57-3.46)
Renal or liver dysfunction  109(6.3) 0.43(0.35-0.51) 43(11.3) 0.72(0.5-0.94)
Septicaemic shock  45(2.6) 0.18(0.12-0.23) 36(9.4) 0.60(0.4-0.8)
Peripartum hysterectomy 86(4.9) 0.34(0.26-0.41) 16(4.2) 0.27(0.13-0.4)
Pulmonary embolism  65(3.7) 0.25(0.19-0.32) 15(3.9) 0.25(0.12-0.38)
Uterine rupture 33(1.9) 0.18(0.11-0.24) 13(3.4) 0.22(0.1-0.34)
Pulmonary oedema  34(1.9) 0.13(0.09-0.18) 10(2.6) 0.17(0.06-0.27)
Acute respiratory dysfunction  28(1.6) 0.11(0.07-0.15) 9(2.4) 0.15(0.05-0.25)
Eclampsia  44(2.5) 0.17(0.12-0.22) 8(2.1) 0.13(0.04-0.23)
Interventional radiology 26(1.5) 0.1(0.06-0.14) 7(1.8) 0.12(0.03-0.2)
Cerebrovascular event  18(1) 0.07(0.04-0.1) 3(0.8) 0.05(0-0.11)
Status epilepticus  5(0.3) 0.02(0-0.04) 2(0.5) 0.03(0-0.08)
Cardiac arrest  17(1) 0.07(0.03-0.1) 1(0.3) 0.02(0-0.05)
Coma  0(0) 0(0-0) 0(0) 0 (0-0)
Anaesthetic problem  20(1.1) 0.08(0.04-0.11) 0(0) 0 (0-0)
Total women affected 1744(100) 6.84(6.51-7.16) 381(100) 6.35 (5.7-7)
Note: n represents number of women affected by the specific morbidity; % is based on the total number of women affected; rate is per 1,000 maternities; 95% 
CI=95% confidence interval; ICU=intensive care unit; Uterine rupture was not recorded by the audit in 2011 unless associated with MOH.
Specific morbidities
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There were 43 reported cases involving renal 
or liver dysfunction in 2015 (Table 2). The 
incidence rate of 0.72 per 1,000 maternities 
was 1.8 times the rate of 0.41 per 1,000 in 
2011-2014. There were 16 reported cases of 
peripartum hysterectomy (PH) in 2015. The 
national PH rate in Ireland in 2015 is 0.27 per 
1,000 maternities or approximately one in every 
3,750 maternities. This rate is slightly lower 
to national rates reported in previous studies 
conducted in Ireland (0.33 per 1,000 births), the 
United Kingdom (0.33 per 1,000 births) and the 
Netherlands of (0.41 per 1,000 births).14,15,16
Recent reports on maternal mortality in 
Ireland and the UK have identified thrombosis/
thromboembolism as a leading direct obstetric 
cause of maternal death. At 0.25 per 1,000 
maternities or one in 4,616 women, the 
incidence of pulmonary embolism (PE) in 2015 
was the same in 2011-2014. We believe this may 
be an underestimate as many post-natal cases 
will be unknown to maternity units when women 
present to a general hospital.
There were 36 cases of septic shock reported for 
2015, this represents an increase on the 21 cases 
reported in 2014 and 16 cases in 2013. These 
numbers are in contrast with the four reported 
cases in each of the first two years of the audit. 
This may be a true increase in incidence or may 
be associated with an increased awareness and 
recognition of sepsis. 
While the number of cases was small, there were 
nine cases of acute respiratory dysfunction 
reported in 2015, this is slightly lower than the 
number reported in 2014 (n=14).
Figure 1: Trend in the rate of severe maternal morbidity (SMM), major obstetric haemorrhage 





























overall increase of 29% (rate ratio=1.29, 
95% CI=1.04-1.59, p-value=0.021), which 
is statistically significant and beyond what 
might be expected in variation of rates of 
such magnitude. In addition, the incidence 
of maternity admissions into an ICU/
CCU has increased by 84.3% during 2011-
2015 (rate ratio=1.84, 95% CI=1.45-2.33, 
p-value<0.001). Figure 1 illustrates the trend 
in the rate of SMM as defined in this audit 
and the separate trends for MOH and ICU/CCU 
admission.
14 Knight M, Kurinczuk JJ, Spark P and Brocklehurst P. United Kingdom Obstetric Surveillance System
(UKOSS) Annual Report 2007. National Perinatal Epidemiology Unit, Oxford.
15 Kwee A, Bots ML, Visser GH, Bruinse HW. Emergency peripartum hysterectomy:a prospective study in The Netherlands. Eur 
J Obstet Gynecol Reprod Biol 2006;124(2):187–92
16 Campbell, Sarah M. et al. Peripartum hysterectomy incidence, risk factors and clinical characteristics in Ireland. Eur J Obstet 
Gynecol Reprod Biol 2016, Volume 207 , 56 - 61
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Table 3 details the specific SMMs involved in 
the 181 cases admitted into an ICU/CCU. One 
in three of these cases involved MOH (35.4%), 
8.8% involved septic shock, 5.0% involved 
peripartum hysterectomy, 3.9% involved 
renal or liver dysfunction and 3.9% involved 
acute respiratory dysfunction.
It is notable that half of the women admitted 
into an ICU/CCU in 2015 had not experienced 
a severe morbidity as defined in this audit 
(45.3%, n=82 of 181). This phenomenon has 
increased over the five years of the audit. 
The proportion of cases admitted to an ICU/
CCU with no associated severe morbidity was 
25% in 2011; 35% in 2012; 41% in 2013; 48% 
in 2014 and 45% in 2015 (2011: n=28 of 111, 
25.2%; 2012: n=46 of 130, 35.4%; 2013: n=53 
of 131, 40.5%; 2014 n=82 of 171, 47.7%; 2015 
n=82 of 181, 45.3%).
Almost half (n=39, 47.6%) of these cases 
occurred in three small maternity units with 
on-site ICU facilities but without obstetric 
high dependency facilities. Feedback from 
these units indicated that the rate of such ICU/
CCU admissions reflected resource issues in 
cases where women required a higher level 
of monitoring. In these three units, more than 
half of the 39 ICU admissions with no other 
SMM as defined in this audit required Level 
1 Care (n=22, 56.4%) and the other 17 cases 
required Level 2 Care (43.6%).
Table 3: Specific severe maternal morbidities (SMMs) associated with admission to an intensive 
care unit or coronary care unit (ICU/CCU) in Ireland, 2015
 N(%) 
Major obstetric haemorrhage  64(35.4)
Septicaemic shock  16(8.8)
Peripartum hysterectomy 9(5)
Renal or liver dysfunction  7(3.9)
Acute respiratory dysfunction  7(3.9)
Pulmonary embolism  5(2.8)
Pulmonary oedema  3(1.7)
Interventional radiology 3(1.7)
Eclampsia  2(1.1)
Cerebrovascular event  2(1.1)
Uterine rupture 1(0.6)
Cardiac arrest  1(0.6)
Status epilepticus  1(0.6)
Coma  0(0)
Anaesthetic problem  0(0)
None of the above 82(45.3)
Total women admitted to ICU/CCU 181 (100)
Note: n represents number of women affected by the specific morbidity; % is based on the total number of women admitted 
to ICU/CCU in 2015.
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Nine of the 18 units that participated in the SMM 
audit also classified their deliveries into one of ten 
groups, as per the Robson Ten Group Classification 
System17 (Appendix F). The 44,473 deliveries in 
these units constituted over seventy percent 
(74.1%) of the 60,006 deliveries in the 18 units 
that participated in the SMM audit. The incidence 
of MOH and of SMM, excluding the criteria for MOH, 
in the nine maternity units submitting Robson 
Classification data is detailed in Table 4.
For the nine units, the MOH rate was 2.7 per 
1,000 deliveries and the rate of other SMM was 
1.9 per 1,000. Notwithstanding the relatively 
small numbers involved when examining by 
Robson Group, there was evidence of increased 
risk of MOH in Group 8 (women with multiple 
pregnancies) and increased risk of SMM, 
excluding the criteria for MOH, in Group 10 
(women with premature deliveries).
Update Variation by Robson Classification
17 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/S0965539501000122. 
Note: Rates per 1,000. Poisson 95% confidence intervals were calculated. CS=Caesarean section; *Other SMM excludes cases of MOH and cases of ICU 
admission only; Robson Group could not be determined for 10 MOH cases and 16 cases of other SMM. 
Table 4: Incidence of major obstetric haemorrhage (MOH) and severe maternal morbidity (SMM) excluding MOH 
by Robson Group in nine Irish maternity units, 2015
Group Group description Deliveries Delivered 
by CS
MOH Other SMM*
N % N Rate  
95% CI
N Rate  
95% CI












cephalic, >37/40 induced or 
elective CS





previous CS), singleton, 
cephalic, >37/40, 
spontaneous labour





previous CS), singleton, 
cephalic, >37/40 induced or 
elective CS




Previous CS, singleton, 
cephalic, >37/40, induced or 
elective CS
6,459 78.9 23 3.6(2.26-5.34) 12
1.9
(0.96-3.25)
6 All nulliparous women with a single breech pregnancy 848 96.7 - - 2
2.4
(0.29-8.52)











All women with a single 
pregnancy with a transverse 
or oblique lie, including women 
with previous uterine scars
123 100 - - 0 0
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Number of maternities in 2015
Unit SMM rate National SMM rate 95% Limits 99.8% Limits
Variation in the 2015 SMM rate across the 
participating eighteen maternity units is 
illustrated in the funnel plot in Figure 2. The 
solid line represents the national SMM rate 
(6.35 per 1,000 maternities). The dashed lines 
represent the limits within which 95% of units 
are expected to lie (i.e. within two standard 
deviations). The solid black lines represent the 
limits within which 99.8% of units are expected 
to lie (i.e. within three standard deviations). 
These limits are adjusted according to the 
number of maternities at each unit and are 
wider for smaller units reflecting the greater 
volatility in rates based on small numbers. 
In regards to the 95% confidence limits, we 
can expect, on average, one in twenty units 
to have a rate outside the dashed lines. 
However, differences between units must 
be interpreted with caution as they may not 
reflect care given but could reflect differences 
in levels of reporting and/or differences in the 
risk profile of the pregnant women presenting 
to the units.
Variation in rates by maternity unit
From Figure 2, it can be seen that five units 
have an outlying SMM rate above the 95% 
upper limit and three units have an outlying 
SMM rate above the 99.8% upper limit. The 
rate for the most outlying unit is three times 
the national rate (18.90 vs. 6.35 per 1,000 
maternities). The rate for the two outlying 
units is over twice the national rate (15.22 
and 15.11 per 1,000).
Half of the SMM cases for the most outlying unit 
(n=15 of 30, 50.0%) were reported because 
they met the SMM criterion of being admitted 
to an ICU/CCU with no other SMM experienced 
as defined in this audit. Feedback from these 
units identified that these are cases requiring 
monitoring above normal ward standard and 
due to low levels of staff in the unit, this could 
only be achieved by admission to the ICU.
It can also be seen from Figure 2 that two of 
the country’s four large maternity hospitals 
had a SMM rate below the lower limit of the 
confidence interval (4.60 vs. 6.35 per 1,000 
maternities and 4.01 vs. 6.35 per 1,000 
maternities).
The funnel plot in Figure 3 illustrates the 
variation in the SMM rate by maternity unit 
after exclusion of cases admitted to an 
ICU/CCU with no other SMM experienced as 
defined in this audit. The adjusted national 
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SMM rate was 4.98 per 1,000 maternities. The 
plot shows that three units have an outlying 
SMM rate above the 95% upper limit and two 
units have an outlying SMM rate above the 
99.8% upper limit. These two units have been 
notified in accordance with the National Office 
of Clinical Audit (NOCA) escalation process. 
The rate for each of these two outlying units 
is twice the national rate (10.78 and 9.57 per 
1,000 maternities). 
Figure 3: Funnel plot of the rate of severe maternal morbidity (SMM) by maternity unit excluding 
cases admitted to an ICU/CCU with no other SMM experienced as defined in this audit, 2015
Figure 4: Funnel plot of the rate of major obstetric haemorrhage (MOH) by maternity unit, 2015
Figure 4 illustrates variation in the rate of MOH 
across the eighteen participating maternity 
units in 2015. Three units had a rate above 
the 95% upper limit for the national rate of 
3.00 per 1,000 maternities and two units had 
a rate above the 99.8% upper limit. These two 
units have been notified in accordance with 
the National Office of Clinical Audit (NOCA) 
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escalation process. The rate for one of the most 
outlying unit is over three times the national 
rate (9.51 vs. 3.00 per 1,000 maternities).
The MOH rate for the other outlying unit is 2.5 
times (7.56 vs. 3.00 per 1,000 maternities) 
the national rate.
Three units with high MOH rates in 2014 
followed the National Office of Clinical Audit 
(NOCA) escalation process and reviewed 
their data and related clinical practices. One 
unit was found to have overestimated their 
number of MOH cases. One unit identified 
the need to use a more rigorous method 
of estimating blood loss which they have 
adopted. The third unit confirmed that their 
quantitative approach for estimating blood 
loss led to effective case ascertainment.
Figure 5: Funnel plot of the average rate of major obstetric haemorrhage (MOH) by maternity 
unit, 2011-2015
Based on the five years of data from the SMM 
audit (2011-2015), we calculated the average 
rate of MOH for the eighteen maternity units 
that participated in 2015 (Figure 5). The 
95% and 99.8% confidence interval around 
the national rate for this five-year period is 
narrower than in the annual funnel plots, a 
result of the increased numbers involved.
The plot shows evidence of excessive 
variation in the MOH rate across the 18 units. 
Eight units had a rate lying outside the limits 
of the 95% confidence interval (five above the 
upper 95% limit and three below the 95% lower 
limit). Four units had a rate lying outside the 
limits of the 99.8% confidence interval (three 
above the upper 99.8% limit and one below 
the 99.8% lower limit). Variances in rates of 
MOH between units may reflect variances 
in practices of estimating blood loss. A 
quantitative approach involving volume and 
weight assessment to estimate blood loss 
should be considered for use in all maternity 
units. Development of a national tool-kit would 
assist standardisation of such an approach. 
We recommend the development and national 
implementation of a specific proforma to 
improve management and documentation 
during a major obstetric haemorrhage event, 
whether in the antenatal or postnatal period.
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 Age group SMM SMM SMM SMM  All maternities SMM rate Rate ratio
  2012 2013 2014* 2015* 2015 2015 (95% CI)
  (N=283) (N=319) (N=363) (N=380)  (95% CI)
 <20yrs 3(1.0) 6(1.9) 5(1.4) 3(0.8) 1.8% 2.78 0.47
       (-0.43-5.99) (0.15-1.48)
 20-24yrs 14(4.8) 20(6.2) 33(9.1) 34(8.9) 8.7% 6.53 1.09
       (4.29-8.76) (0.72-1.65)
 25-29yrs 60(20.5) 44(13.6) 57(15.7) 68(17.9) 19.0% 5.97 (Ref.)
       (4.53-7.42) 
 30-34yrs 88(30.1) 118(36.5) 126(34.7) 121(31.8) 36.2% 5.56 0.93
       (4.56-6.57) (0.69-1.25)
 35-39yrs 97(33.2) 100(31.0) 110(30.3) 119(31.3) 28.0% 7.08 1.18
       (5.78-8.37) (0.88-1.6)
 ≥40yrs 30(10.3) 35(10.8) 32(8.8) 35(9.2) 6.3% 9.28 1.55
       (6.16-12.41) (1.03-2.34)
Note: Values are shown as n(%) unless otherwise stated. Data for all maternities are from Perinatal Statistics Report 2015. Healthcare Pricing Office (HPO). 
Dublin: HPO, 2017. SMM rate per 1,000 births. * Maternal age was not known for two women in 2014 and one woman in 2015. Poisson 95% confidence 
intervals were calculated for the rare ratios.
Table 5: Age distribution of women who experienced severe maternal morbidity (SMM), 2012-2015
Age
Maternal age, was recorded for 380 of the 381 
cases of severe maternal morbidity (SMM) 
in 2015 and ranged from 15 to 50 years. 
The mean age was 32.6 years (standard 
deviation = 5.6 years). The age distribution of 
women who experienced SMM in 2012-2015 
is detailed in Table 5. In 2015, 63.1% were 
aged 30-39 years which was similar to the 
population of women who gave birth in 2015 
(64.2%). Women aged 35 years or over were 
somewhat overrepresented: they accounted 
for 40.5% of SMM cases in 2015 compared 
to 34.3% of the population who gave birth 
that year. This is reflected in the SMM rate 
calculated by maternal age based on data for 
2015 (Table 5), whereby the highest SMM rate 
was among 35-39 year-olds and women over 
40 years of age.
Maternal characteristics
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Ethnicity
There are no national data available on 
ethnicity for the pregnant population in 
Ireland. The distribution by ethnic group of the 
women who experienced SMM in 2015 broadly 
reflected that of the general population of 
women aged 15-49 years as reported from 
the most recent national census (Table 6).18 
In those who experienced SMM there was an 
overrepresentation of women whose ethnicity 
was described as Asian or Black as they made 
up 7.6% of SMM cases but only 4.0% of the 
population aged 15-49 years.
Body mass index
Body mass index (BMI) for the women who 
experienced SMM in 2015 ranged from 16.9 to 
47.3kgm-2. BMI was not known for 37 (9.7%) of the 
women. This level of reporting of BMI is slightly 
lower to that for SMM cases in 2014 (12.1%). Less 
than half of the women who experienced SMM 
had a BMI in the normal range (47.1%), 29.1% were 
overweight and 22.4% were obese (Table 7). This 
BMI profile closely matches that of the women 
in the 2015 Healthy Ireland Survey.19 However, 
interpretation of this comparison must 
consider the weight gain due to pregnancy 
for the women who experienced SMM as the 
Healthy Ireland Survey was of the general 
population. However, there are no national data 
available on BMI for the pregnant population.
 SMM 15-49 year-old
 2015 female population, 2016
 (N=381) % 
White Irish 298(78.2) 77.1
Irish Traveller 7(1.8) 0.7
Other white background 43(11.3) 13.3
Asian/Asian Irish 10(2.6) 2.7
Black/Black Irish 19(5.0) 1.6
Other/mixed - 1.8
Not recorded 4(1.0) 2.7
BMI category (kgm-2) SMM Healthy Ireland
 2015 Survey 2015
 (N=344)* % 
Underweight (<18.5) 5(1.5) 3
Healthy (18.5-24.9) 162(47.1) 44
Overweight (25.0-29.9) 100(29.1) 31
Obese (≥30.0) 77(22.4) 22
Note: Values are shown as n(%) unless otherwise stated.
Note: Values are shown as n(%) unless otherwise stated. * BMI was not known for 37 women. 
Table 6: Ethnicity of women who experienced severe maternal morbidity (SMM), 2016
Table 7: Body mass index (BMI) of women who experienced severe maternal morbidity (SMM), 2015
18 Central Statistics Office. Profile 7 Religion, Ethnicity and Irish Travellers. 2012. Dublin: The Stationary Office. 
19 Ipsos MRBI (2015). Healthy Ireland Survey 2015. Dublin: The Stationery Office.
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Smoking, alcohol and drug misuse
Smoking status at the time of the first hospital 
booking appointment was not known for 
10.5% of the women (n=40). Of the remainder, 
ten percent were reported to have been 
smoking at the time of the first booking (34 
of 341, 10.0%). The prevalence of smoking 
during pregnancy is not routinely published 
for all Irish pregnancies but rates of 12%, 15%, 
16% and 19% have been reported for England, 
Northern Ireland, Wales and Scotland, 
respectively.20
The quantity smoked was recorded for 28 of 
the 34 women who were smokers at the time 
of the first hospital booking appointment. On 
average, they smoked 10 cigarettes per day, 
ranging from two to 20. Of the 34 women who 
reported smoking at the time of their first 
booking appointment, five were reported to 
have given up smoking during pregnancy 
(n=5 of 31, 16.1%, unknown for three cases).
Alcohol drinking status at the time of the 
first hospital booking appointment was not 
known for 21% of the women (n=81, 21.3%). 
Of the 300 women with available data, only 
1.7% were reported to be drinking alcohol 
(n=5). Four women (1.1%, n=4 of 375, 
unknown for six cases) were recorded as 
having a documented history of drug abuse or 
attendance at a drug rehabilitation unit.
Previous pregnancy
Forty percent (40.8%) of the women who 
experienced SMM in 2015 were nulliparous 
which is similar with previous years (Table 8). 
Women who had had one previous completed 
pregnancy, i.e. para 1, were underrepresented 
among the SMM cases when compared with 
the population of women birthing in Ireland 
in 2015 (28.4% versus 34.8%). As a corollary, 
women of higher parity and nulliparous 
women were slightly overrepresented among 
the SMM cases compared with the overall 
population.
Previous early pregnancy loss was reported 
for almost one third of the women who 
experienced SMM in 2015 (124 of 378, 32.8%; 
unknown for three women). Eighteen women 
(4.8%) had previously experienced three or 
more pregnancies that ended before 24 weeks 
gestation.
The prevalence of a previous caesarean section 
was over 40% among the women who had 
previously given birth (n=90 of 218, 41.3%; not 
known for nine women).
20 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com
Parity SMM  SMM SMM SMM  All maternities
 2012 2013 2014 2015 2015
 (N=288)* (N=321)* (N=359)* (N=380)* 
Nulliparous 119(41.3) 122(38.0) 152(42.3) 155(40.8) 38.3%
Para 1 88(30.6) 97(30.2) 101(28.1) 108(28.4) 34.8%
Para 2 43(14.9) 55(17.1) 67(18.7) 69(18.2) 17.8%
Para 3+ 38(13.2) 47(14.6) 39(10.9) 48(12.6) 9.1%
Table 8: Distribution of parity for women who experienced severe maternal morbidity (SMM), 2012-2015
Note: Values are shown as n(%) unless otherwise stated; * Parity was not known for four, two, six and one cases in 2012, 2013, 2014 and 2015, 
respectively. Data for all maternities are from Perinatal Statistics Report 2015. Healthcare Pricing Office (HPO). Dublin: HPO, 2017
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Early pregnancy loss (before 24 weeks 
gestation and birthweight less than 500g) 
was experienced by 19 of the 379 women 
(5.0%, unknown for two cases). These 
involved 10 cases of miscarriage (2.6%), 
nine cases of ectopic pregnancy (2.4%). 
Twelve of the early pregnancy loss cases 
were diagnosed with one SMM (five cases 
of miscarriage and seven cases of ectopic 
pregnancy) and seven cases were diagnosed 
with two SMMs (five cases of miscarriage 
and two cases of ectopic pregnancy). 
Admission to ICU and MOH were the most 
frequently reported SMM, associated with 
twelve and nine cases of early pregnancy 
loss, respectively. There were three cases 
of septicaemic shock, all associated with 
miscarriage. Other reported SMMs included 
uterine rupture (n=1) and interventional 
radiology (n=1).
Of the 360 women whose SMM was not 
associated with early pregnancy loss, 23 
had a multiple birth (n=23 of 360, 6.4%; 
Table 10). Twenty two of the multiple births 
involved twins and one involved triplets. 
In Ireland in 2015, multiple births made up 
1.9% of all maternities (n=1,152 of 60,006 in 
maternity units participating in this audit). 
Thus, multiple pregnancy was almost four 
times (3.6 times) more common in cases 
of SMM than in all maternities, a reflection 
of the increased risk of SMM associated 
with multiple pregnancy. This is evident 
from the national SMM rate of 5.7 per 1,000 
maternities associated with singleton 
pregnancy in 2015 and a 4 times higher 
rate of 20 per 1,000 maternities for multiple 
pregnancy (p-value<0.001). 
These findings are similar to findings from 
Scotland where 6.4% of SMM cases with 
available data in 2012 were associated with 
twin pregnancies, four times higher than 
their proportion of twin births in 2012 (1.5%).
For 9% of the women who experienced SMM 
in 2015, their pregnancy was the result of 
infertility treatment (n=40 of 349, 11.5%; 
unknown for 32 women). In over half of these 
cases the method of infertility treatment was 
in vitro fertilisation (n=23 of 40, 57.5%).
Gestation at delivery or pregnancy end ranged 
from three to 42 weeks. For two thirds of the 
women affected (66.2%), their pregnancy 
went full term (Table 9). For a further 17.0%, 
their pregnancy ended at moderate to late 
pre-term gestation (32-36 weeks). For 5.3% 
of the women, the end of pregnancy occurred 
before 22 weeks gestation.
 2012 2013 2014 2015
 (N=287)* (N=317)* (N=348)* (N=376)*
Pre-viable (<22wks) 15(5.2) 11(3.5) 14(4.0) 20(5.3)
Extremely pre-term (22-27wks) 4(1.4) 15(4.7) 14(4.0) 14(3.7)
Very pre-term (28-31wks) 22(7.7) 14(4.4) 19(5.4) 25(6.6)
Moderate/late pre-term (32-36wks) 50(17.4) 73(23.0) 78(22.3) 64(17.0)
Term (37-41wks) 192(66.9) 204(64.4) 224(64.0) 249(66.2)
Post-term (42wks+) 4(1.4) 0(0.0) 1(0.3) 4(1.1)
Table 9: Gestation at delivery or pregnancy end for women who experienced severe maternal morbidity, 2012-2015
Note: Values are shown as n(%) unless otherwise stated; * Gestation was not known for five, six ,15 and five cases in 2012, 2013, 2014 and 2015, respectively.
Pregnancy associated with the severe maternal morbidity event
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 SMM SMM SMM SMM All SMM rate Rate ratio
 2012 2013 2014 2015 maternities (95% CI) (95% CI)
 (N=292) (N=323) (N=338)* (N=360)** 2015 
Single 273(93.5) 296(91.6) 314(92.9) 337(93.6%) (98.1%) 5.73 1.00
      (5.12–6.34) (Ref.)
Multiple 19(6.5) 27(8.4) 24(7.1) 23(6.4%) (1.9%) 19.97 3.55
      (19.81-20.13) (2.33-5.42)
Table 10: Single and multiple birth for women who experienced severe maternal morbidity (SMM), 2012-2015
Note: Data for all maternities are from Perinatal Statistics Report 2015. Healthcare Pricing Office (HPO). Dublin: HPO, 2017. Values are shown as n(%) 
unless otherwise stated. SMM rate per 1,000 births. *Not known for nine of the 347 women in 2014 whose SMM was not associated with early pregnancy 
loss.**Single and multiple births in women in 2015 whose SMM was not associated with early pregnancy loss. Poisson 95% confidence intervals were 
calculated for the rare ratios.
Mode of delivery
Of the 360 women whose SMM was not 
associated with early pregnancy loss in 2015, 
the mode of delivery for two thirds of the 
women was caesarean section (Table 11). This 
is over twice the 31.3% caesarean section rate 
occurring in all births nationally in 2015.21 The 
majority of caesarean sections in cases of SMM 
were carried out prior to labour which may 
reflect the clinical complexity of the pregnancy 
rather than mode of delivery influencing risk of 
SMM. Over one in three women had a vaginal 
delivery, usually spontaneously (20.9%).
  2012 2013 2014 2015
  (N=275)* (N=309)* (N=337)* (N=358)*
Vaginal 82(29.8) 102(33.0) 114(33.8) 127(35.5)
 Spontaneous 56(20.4) 73(23.6) 67(19.9) 75(20.9)
 Assisted breech 2(0.7) 3(1.0) - 7(2)
 Ventouse 10(3.6) 16(5.2) 25(7.4) 29(8.1)
 Non-rotational forceps 14(5.1) 10(3.2) 18(5.3) 16(4.5)
 Rotational forceps - - 4(1.2) -
Caesarean section 193(70.2) 207(67.0) 223(66.2) 231(64.5)
 Elective LSCS (no labour) 64(23.3) 59(19.1) 54(16.0) 65(18.2)
 Elective LSCS (labour) 5(1.8) 5(1.6) 7(2.1) 3(0.8)
 Emergency LSCS (no labour) 52(18.9) 77(24.9) 99(29.4) 81(22.6)
 Emergency LSCS (labour) 71(25.8) 63(20.4) 61(18.1) 81(22.6)
 Classical 1(0.4) 3(1.0) 25(7.4) 1(0.3)
Note: Values shown are n(%) unless otherwise stated; * Mode of delivery was not known for one, two, ten cases and two cases in 2012, 2013, 2014 
and 2015, respectively. For cases of multiple birth when mode of delivery differed for the babies, the more complex mode of delivery was taken as 
the primary mode. LSCS=Lower segment caesarean section. Data excludes 16, 12, 18 and 19 cases of early pregnancy loss in 2012, 2013, 2014 
and 2015, respectively.
Table 11: Primary mode of delivery (excluding those who experienced early pregnancy loss) for women who 
experienced severe maternal morbidity, 2012-2015
21 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. 
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
SMM Report 2015 250917.indd   29 25/09/2017   16:01
30  Severe Maternal Morbidity in Ireland Annual Repor t 2015
Maternal care details
Data on the level of maternal care 
provided was available for 378 of the 381 
SMM cases. Virtually all of the women 
who experience SMM in 2015 required 
an increased level of support/critical 
care (Table 12). Almost half required Level 
1 Care (48.9%), 43.1% required Level 2 Care 
and 5.8% required Level 3 Care.
*Note: Level of Care not known for three of the 381 women.
*Note: Level of Care not known for 3 women; ICU=intensive care unit.
Table 12: Level of maternal care provided to women during clinical SMM events in Ireland, 2015
Table 13: Level of maternal care provided to women during specific clinical SMM events in Ireland, 2015*
Level of Care Definition N(%)*
Level 0:
Normal ward care
Care of low risk pregnant women 8(2.1)
Level 1:
Additional monitoring or 
intervention, or step down 
from higher level of care
Patients at risk of their condition deteriorating and 
needing a higher level of observation or those recently 




Patients requiring invasive monitoring/ intervention 
including support for a single failing organ system (incl. 





support alone, or support of 
two or more organ systems
Patients requiring advanced respiratory support 
(mechanical ventilation) alone or basic respiratory 











Major obstetric haemorrhage 181(47.9) 1(0.6) 102(56.4) 66(36.5) 12(6.6)
ICU/coronary care unit 
admission 180(47.6) - 69(38.3) 89(49.4) 22(12.2)
Renal or liver dysfunction 43(11.4) - 16(37.2) 25(58.1) 2(4.7)
Septicaemic shock 36(9.5) - 13(36.1) 19(52.8) 4(11.1)
Peripartum hysterectomy 16(4.2) - 5(31.3) 7(43.8) 4(25.0)
Pulmonary embolism 15(4) 4(26.7) 7(46.7) 3(20) 1(6.7)
Uterine rupture 13(3.4) 3(23.1) 4(30.8) 5(38.5) 1(7.7)
Pulmonary oedema 10(2.6) - 1(10) 9(90) -
Eclampsia 8(2.1) - 1(12.5) 7(87.5) -
Interventional radiology 7(1.9) - 1(14.3) 5(71.4) 1(14.3)
Acute respiratory 
dysfunction 6(1.6) - - - 6(100)
Cerebrovascular event 3(0.8) - - 3(100) -
Status epilepticus 2(0.5) - 1(50) - 1(50)
Cardiac arrest 1(0.3) - - - 1(100)
Anaesthetic problem - - - - -
Total 378(100) 8(2.1) 185(48.9) 163(43.1) 22(5.8)
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Of the women admitted to an ICU/CCU, 12.2% 
required Level 3 Care; half required Level 2 Care; 
and 38.3% required Level 1 Care (Table 13). This 
highlights that admission to an ICU/CCU does not 
infer that a woman has a requirement for Level 
3 Care. Of the 69 women who were admitted to 
an ICU/CCU and required Level 1 Care only, 59% 
(n=41, 59.4%) did not experience another SMM 
as defined by this audit.
For MOH, the majority of cases required 
Level 1 Care (56.4%), 36.5% required Level 
2 Care and 6.6% requiring Level 3 Care. As 
expected clinically, higher levels of critical 
care/monitoring were required for the women 
experiencing life-threatening maternal 
morbidities, e.g. acute respiratory dysfunction 
and cardiac arrest.
Neonatal outcomes
Of the 360 women whose SMM was not 
associated with early pregnancy loss, a total 
of 384 babies were delivered (data on early 
pregnancy loss were not known for two women). 
There were 337 singleton births, 22 twin births 
and one birth of triplets. Thus, a total of 384 
babies were delivered. Information on neonatal 
outcome in terms of perinatal death was 
available for 383 of these 384 infants (93.5%). 
Of the 383 births, there were nine stillbirths and 
eleven early neonatal deaths and no known late 
neonatal deaths. Therefore, in total, there were 
374 live born infants.
All of the 20 perinatal deaths were associated 
with singleton pregnancies. Gestation at delivery 
occurred before 22 weeks for one woman (5.0%), 
for four women (20.0%) it was extremely pre- 
term (22-27 weeks), for eleven women (55.0%) it 
was pre-term (28-36 weeks) and for four women 
(20.0%) it occurred at term (37-41 weeks). Major 
obstetric haemorrhage affected three quarters of 
the 20 women (n=15, 75.0%).
The perinatal mortality rate based on the 20 
stillbirths and early neonatal deaths among 
the 383 infants was 52.2 per 1,000 births, i.e. 
approximately 5.2% or one in 19 of the infants 
died. This rate was 7.5 times the perinatal 
mortality rate observed for all births in Ireland 
in 2015 (p-value<0.001; Table 14). However, 
the rate is in line with the perinatal mortality 
rate among infants born to women with SMM in 
Scotland in recent years, which ranged from 17 
to 64 per 1,000 maternities. 22
22 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
Nine percent (n=34, 9.1%) of the 374 live born 
infants were intubated following delivery and 
less than half (n=177, 48.8%) were transferred 
to the Special Baby Care Unit (SBCU) or 
Neonatal Intensive Care Unit (NICU; Table 15).
 (N=374)
Intubation following delivery (%) 34  (9.1%)
Transfer to SBCU/NICU (%) 177 (47.3%)
Table 15: Selected neonatal outcomes by number of gestations, 2015 
Note: SBCU=Special Baby Care Unit; NICU=Neonatal Intensive Care Unit.
 Perinatal deaths Births PMR Rate ratio
   (95% CI)  (95% CI)
All births 2015* 460 65,904 7.0 (6.3-7.6) 1.0 (Ref.)
SMM 2015 20 383 52.2 (29.5-75) 7.5 (4.8-11.7)
Table 14: Perinatal mortality among infants born to women with SMM in Ireland in 2015 compared to 
perinatal mortality among all infants born in Ireland
Note: PMR=perinatal mortality rate per 1,000 births; * IB O’Farrell, Corcoran P, Manning E, McKernan J , Greene RA, on behalf of the Perinatal 
Mortality Group. Perinatal Mortality in Ireland Annual Report 2015. Cork: National Perinatal Epidemiology Centre, 2017. Poisson 95% confidence 
intervals were calculated for the rare ratios.
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23 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and 
Gynaecologists,  Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health 
Service Executive
24 Royal College of Obstetricians and Gynaecologists (2011).Maternal Critical Care Working Group. Providing equity of critical 
and maternity care for the critically ill pregnant or recently pregnant woman. 
This section of the report presents findings 
from the audit of critical care in obstetrics 
in Ireland in 2015. This audit was conducted 
independently from the SMM report.  The 
purpose of this audit was to address the 
dearth of national data on the prevalence 
rates for women who require Level 2 and 
Level 3 Care and the location where higher 
levels of care are provided. While all Level 3 
intensive care patients will be admitted to a 
Level 3 Care Unit and be readily identifiable 
in future national Intensive Care National 
Audit and Research Centre (ICNARC) data, 
estimation of the requirement for Level 
2 Care i.e. high dependency care, is more 
complicated.  Women requiring Level 2 
Care may have all or part of their critical 
care needs met in a maternity unit, but at 
the present time there is no national data 
recording this activity. 
Fifteen of the nineteen Irish maternity units 
have contributed data to this audit; two 
large tertiary referral maternity units and 13 
smaller maternity units. 
Levels of critical care
National and International guidelines 
have recommended that the terms high 
dependency and intensive care be replaced 
by the term critical care.23,24 The term critical 
care has a more precise definition whilst the 
terms maternal critical care, high dependency 
care and high risk maternity care are not 
interchangeable. Within the term critical care, 
care is subdivided into four levels, dependent 
on organ support and the level of monitoring 
required independent of clinical diagnosis 
(Appendix G).
Main findings
Overall, 347 women, out of 41,517 maternities 
cared for in the fifteen reporting units, required 
either Level 2 or Level 3 Care (Table 16). This 
gives a rate of 8.36 per 1,000 maternities or 
one in 120 maternities. Of these, 329 women 
required Level 2 Care only (7.92 per 1,000 
maternities or one in 126 maternities) and 18 
women required Level 3 Care, either solely or 
in combination with Level 2 Care, during the 
clinical event (0.43 per 1,000 maternities or 
one in 2,307 maternities). 
Level of Critical Care N(%) 
Level 2 Care only 329(94.8)
Level 2 followed by Level 3 Care 1(0.3)
Level 2 followed by Level 3 followed by Level 2 Care 3(0.9)
Level 3 Care only 6(1.7)
Level 3 followed by Level 2 Care 8(2.3)
Table 16: Sequence of critical care provided to women who required Level 2 or 3 Care, 2015
Confidential Audit of Critical Care in Obstetrics in Ireland
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Note: The duration of Level 2 Care was unknown for two women who required Level 2 Care only.
Duration of critical care
The duration of Level 2 Care was known for 
327 of the 329 women who required Level 2 
Care only. The maximum duration of Level 
2 Care only was 17 days, and for the vast 
majority (96.9%), the duration of Level 2 Care 
did not exceed four days. Of the 18 women 
who required Level 3 Care, the maximum 
duration of Level 3 Care was 10 days. For the 
vast majority (77.8%), the duration of Level 3 
Care did not exceed four days (Figure 6).
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Table 17: Body mass index (BMI) of women who required Level 2 or Level 3 Care, 2015
Note: Values are shown as n(%) unless otherwise stated. * BMI was not known for 41 women who required Level 2 or Level 3 
Care and 37 SMM cases.
Data on pre-existing co-morbidities was 
available for 315 of the 329 women who required 
Level 2 Care only and 17 of the 18 women who 
required Level 3 Care. Over forty percent of the 
women requiring Level 2 Care only had pre-
existing co-morbidities and over half of the 
women requiring Level 3 Care had pre-existing 
co-morbidities (Level 2 Care only: n=131, 41.6%; 
Level 3 Care: n=9, 52.9%; Figure 7).
The pregnancy risk level during the antenatal 
period was recorded for 306 of the 329 women 
requiring Level 2 Care only and 16 of the 18 
women requiring Level 3 Care. The pregnancy of 
forty percent of the women who required Level 
2 Care only had been identified as high risk 
during the antenatal period  (n=123, 40.2%). 
The pregnancy of three quarters of those who 
required Level 3 Care had been identified as 
high risk antenatally  (n=12, 75.0% ; Figure 7).
Pre-existing co-morbidities and antenatal risk assessment
Figure 7: Pre-existing co-morbidities and antenatal risk assessment for women who required 










































Body mass index (BMI) for the women who 
required Level 2 or Level 3 Care in 2015 
ranged from 16.7 to 50.0 kgm-2. BMI was not 
known for 41 of the 347 women. This level of 
BMI reporting is similar to that for SMM cases 
in 2012, 2013 and 2014. Forty five percent 
(n=137, 44.8%) of the women had a BMI in the 
healthy range, 27.8% (n=85) were overweight 
and 26.1% % (n=80) were obese (Table 17). 
This BMI profile closely matches that of all 
women who experienced SMM in 2015, as 
defined in the NPEC SMM audit, and of the 
general population of women sampled in the 
2015 Healthy Ireland Survey.
BMI category 
(kgm-2)









Underweight (<18.5) 4(1.3%) 5(1.5%) 3
Healthy (18.5-24.9) 137(44.8%) 162(47.1%) 44
Overweight (25.0-29.9) 85(27.8%) 100(29.1%) 31
Obese (≥30.0) 80(26.1%) 77(22.4%) 22
Confidential Audit of Critical Care in Obstetrics in Ireland
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Multiple Pregnancies
Compared to the population of women 
who gave birth in 2015, there was an over-
representation of women with multiple 
pregnancies amongst those who required 
Level 2 or Level 3 Care (Table 19).
Half of the women who required Level 2 or 
Level 3 Care in 2015 were nulliparous (n=182, 
52.9%; Table 18). This is higher than was 
observed among all women who experienced 
SMM in 2015 and is also higher than in the 
population of women who gave birth in 2015, 
thus nulliparous women are over-represented 
amongst those who required Level 2 or Level 3 
Care. The number of multiparous women who 
required Level 2 or Level 3 Care was broadly 
similar to the number who experienced SMM 
in 2015 and in the case of Para 2 and Para 3+ 
women, similar to the population who gave 
birth in 2015. 
Table 18: Distribution of parity for women who required Level 2 or Level 3 Care, 2015
Table 19: Single and multiple births in women who required Level 2 or Level 3 Care, 2015
Note: Values are shown as n(%) unless otherwise stated; * Parity was not known for three women who required Level 2 or Level 
3 Care and one SMM case. Data for all maternities are from Perinatal Statistics Report 2015. Healthcare Pricing Office (HPO). 
Dublin: HPO, 2017
Note: Data for all maternities are from Perinatal Statistics Report 2015. Healthcare Pricing Office (HPO). Dublin: HPO, 2017. 
*Single and multiple births in women in 2015 whose SMM was not associated with early pregnancy loss.








Nulliparous 182(52.9%) 155(40.8%) 38.3%
Para 1 79(23%) 108(28.4%) 34.8%
Para 2 49(14.2%) 69(18.2%) 17.8%
Para 3+ 34(9.9%) 48(12.6%) 9.1%








Single 326(93.9%) 337(93.6%) 98.1%
Multiple 21(6.1%) 23(6.4%) 1.9%
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25 The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM. World Health Organisation 2012
26 World Health Organisation, Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for 
maternal health. World Health Organization; 2011
27 O’Malley E, Popivanov P, Fergus A and Byrne B. Maternal Near Miss: what lies beneath? European Journal Obstetric Gynaecology 
Reproductive  Biology 2016;199
Maternal morbidity in women requiring Level 2 Care
Maternal morbidity was classified as direct, 
indirect or coincidental based on the main 
clinical diagnosis during the critical care event, 
using the WHO classification for maternal 
mortality (Appendix I).25 Briefly described, 
direct maternal morbidities refer to obstetric 
complications of the pregnancy state while 
indirect maternal morbidities refer to medical 
complications resulting from pre-existing 
disease, or disease that developed during 
pregnancy which was not the result of direct 
obstetric causes, but which was aggravated 
by the physiological effects of pregnancy. The 
majority of women (93.6%) requiring Level 2 
Care in this audit were classified as having a 
direct obstetric morbidity; 6.4% had an indirect 
morbidity; there were no cases of coincidental 
morbidity (Table 20). The main causes of direct 
obstetric morbidity in women who required 
Level 2 Care were attributable to hypertensive 
disorders (52.3%) and obstetric haemorrhage 
(28.6%) 
The absence of international consensus on 
definitions of SMM is problematic and impedes 
comparative analysis and uniform case-
identification criteria. The WHO defines severe 
maternal complications as potentially life-
threatening conditions and a maternal near 
miss as a woman who nearly died but survived 
a complication during pregnancy, childbirth or 
within 42 days of termination of pregnancy.26 
Table 20 demonstrates the number of maternal 
morbidities identified using three different 
definitions for maternal morbidity: the NPEC 
SMM, the WHO Near Miss (NM) criteria (Appendix 
J) and the WHO Severe Maternal Complication 
(SMC) criteria (Appendix K). Almost all (96.8%) 
direct causes of SMM satisfied the WHO Severe 
Maternal Complication (SMC) criteria, but 
only fulfilled 12.0% the WHO Near Miss (NM) 
criteria, with a further 12.7% had insufficient 
data to determine the WHO Near Miss (NM) 
criteria. Less than 30% (n=89, 28.9%) of direct 
morbidities fulfilled the NPEC SMM criteria, 
however, 35 (39.3%) of these cases fulfilled the 
criteria due to ICU admission only. 
Considering the NPEC SMM and WHO Near Miss 
(NM) definitions utilise organ dysfunction 
criteria, it is evident that a number of women 
requiring Level 2 Care do not experience 
organ dysfunction as their clinical needs were 
identified and treated before organ dysfunction 
occurred. This is similar to findings of a recent 
study of HDU admissions in a tertiary referral 
maternity unit in Ireland.27
Specific findings for women who required Level 2 Care only
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Table 20: Classification of maternal morbidity in women who required Level 2 Care in 2015 according to the NPEC 
Severe Maternal Morbidity (SMM), WHO Near Miss (NM) and WHO Severe Maternal Complication (SMC) criteria.
Note: The superscripted number under the NPEC SMM categories column indicates the number of cases that fulfilled the criteria of the NPEC SMM audit due 
to ICU admission only. *For the WHO NM criteria, a range is provided: the lower figure indicates the number of cases which met the WHO NM definition and the 
higher number includes cases likely to have met the WHO NM definition but where extra data is required.










All (Direct, Indirect and Coincidental) 329(100%) 158(48%) 39-80(11.9-24.3%) 306(93%)
Direct 308(93.6%) 89(28.9%)35 37-76(12-24.7%) 298(96.8%)
Pregnancy with abortive outcome* 9(2.7%) 3(33.3%)3 2-3(22.2-33.3%) 9(100%)
Hypertensive disorders 172(52.3%) 43(25%)23 5-15(2.9-8.7%) 172(100%)
Obstetric Haemorrhage 94(28.6%) 35(37.2%)7 25-47(26.6-50%) 92(97.9%)
Pregnancy related infection 21(6.4%) 5(23.8%)1 2-6(9.5-28.6%) 21(100%)
Other obstetric complications 10(3%) 3(30%)1 2-4(20-40%) 4(40%)
Unanticipated complications of 
management 2(0.6%) 0(0%)
None 1-1(50-50%) 0(0%)
Indirect 21(6.4%) 5(23.8%)5 2-4(9.5-19%) 8(38.1%)
Non obstetric complications 21(6.4%) 5(23.8%)5 2-4(9.5-19%) 8(38.1%)
Coincidental 0 (0%) 0 (0%)None 0 (%) 0 (0%)
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Of the 329 women who received Level 2 Care, 
basic cardiovascular support (BCVS) was 
the most common (n=240, 72.9%) organ 
support required (Table 21). BCVS constituted 
invasive monitoring, primarily arterial line 
placement, and or IV anti-hypertensive. Of the 
240 women who received BCVS, 40% (n=96) 
had received a magnesium sulphate infusion 
as a prophylaxis of eclampsia in severe pre-
eclampsia.
Almost one in five women who received 
Level 2 Care required neurological support in 
the form of a magnesium sulphate infusion 
with no other organ support required (n=66, 
20.1%). The primary indication for transfusion 
of magnesium sulphate was mainly for the 
prophylaxis of eclampsia (n=64 of 66 cases, 
97.0%).  The decision to include these cases 
as Level 2 Care is based on the equivalent 
monitoring and maternal care required in 
the use of magnesium sulphate infusion 
regardless of whether the indication for use 
is for treatment of or prophylaxis against 
eclamptic seizures. 
Organ support required
Table 21: Single organ support required during Level 2 Care, 2015
Organ support required N (%)
Basic Cardiovascular Support (BCVS) 240(72.9%)
Advanced Cardiovascular Support (ACVS) 3(0.9%)
Basic Respiratory Support (BRS) 9(2.7%)
Basic Cardiovascular Support and Basic Respiratory 
Support (BCVS/ BRS)*
9(2.7%)
Magnesium Sulphate Infusion (Neurological) 66(20.1%)
Renal 1(0.3%)
Hepatic 1(0.3%)
*BRS and BCVS occurring simultaneously during the episode count as a single organ support
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Table 22: Highest level support location for women who required Level 2 Care in 15 Irish maternity units, 2015
Note: For women who were treated in more than one care setting during the clinical event, the setting offering the highest level of support is reported.
For women who required Level 2 Care only, 
the highest support level location during the 
clinical event is detailed in Table 22. Across 
the 15 participating units, over sixty percent 
of these women were treated in an obstetric 
HDU (n=210, 63.8%) and over one in four 
were treated in an ICU/CCU (n=88, 26.7%). 
In maternity units with fewer than 2,500 
births per year, the majority of women (n=66, 
78.6%) requiring Level 2 Care were treated 
in an ICU/CCU. In maternity units with 2,500-
6,000 births per year, one third of women 
(n=17, 34.0%) who required Level 2 Care 
were treated in an ICU/CCU, whereas this 
was very rarely the case in a tertiary referral 
maternity hospital (n=5, 2.6%). Variances 
across hospitals in location of care for women 
requiring Level 2 Care may reflect differences 
in resources available for obstetric Level 2 
Care and a dependence on ICU/CCU facilities. 
HDU and ICU facilities available to maternity 
units in Ireland are illustrated on page 12 of 
this report.
Location during Level 2 Care
No of women 
who required 










All 15 reporting 
units 329 21(6.4%) 2(0.6%) 210(63.8%) 8(2.4%) 88(26.7%)
Maternity units with 








195 0(0%) 0(0%) 190(97.4%) 0(0%) 5(2.6%)
Inter-hospital Transfer
Data on transfer details was available for 325 of 
the 329 women requiring Level 2 Care. Of these 
325 cases, 15 (4.6%) were transferred from 
another maternity unit for Level 2 Care. Of the 
15 cases transferred from another maternity 
unit, the majority (n=14, 93.3%) of transfers 
were within the recipient unit’s HSE hospital 
network group.
 
A range of health care professionals attended 
during the 15 transfers for Level 2 Care and 
in some cases more than one healthcare 
professional was in attendance. Attending 
professionals included: midwife (n=10); 
obstetrician (n=6); anaesthetist (n=6) and a 
surgeon (n=1). 
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28 Clinical Guideline No 25 [2014] The Irish Maternity Early Warning System (IMEWS) Institute of Obstetricians and Gynaecologists, 
Royal College of Physicians of Ireland and Directorate of Clinical Strategy and Programmes, Health Service Executive.
IMEWS
National guidelines recommend the use of the 
Irish Maternity Early Warning System (IMEWS) 
to monitor all women who are clinically pregnant 
or who were delivered within the previous 42 
days.28 In the majority of cases (n=203, 65.1%; 
unknown for 17 cases), an IMEWS was used 
to monitor women prior to commencement of 
Level 2 Care. Of the 109 (34.9%) cases where 
an IMEWS was not used, it was reported that the 
woman was admitted either from home (n=10, 
9.2%) or was cared for in a location which 
utilised a different monitoring tool (theatre, 
n=57, 52.3%; ward, n=2, 1.8%; delivery suite, 
n=37, 33.9%; emergency room/out-patient 
department, n=10, 2.8%).
Following commencement of Level 2 Care, an 
IMEWS was used in the management of over 
half (n=170, 54.3%, unknown for 16 cases) of 
the women.  In incidences when IMEWS was not 
used during Level 2 Care, a different monitoring 
tool was used in the majority of cases (n=128, 
90.1%, unknown for one).
Invasive monitoring
Data on the use of invasive monitoring was 
available for 328 of the 329 women receiving 
Level 2 Care. Of these 328 cases, nearly 
seventy percent (n=228, 69.5%) required 
invasive monitoring, most commonly the 
use of an arterial line. Table 23 outlines the 
incidence of invasive monitoring per category 
of maternal morbidity.
Table 23:  Invasive monitoring of women requiring Level 2 Care in 2015
Note: More than one invasive monitoring procedure was required in some cases therefore the percentages sum to more than 100%.
Maternal monitoring prior to and during Level 2 Care







Pregnancy with abortive 
outcome 4(13.8%) 9(4.1%) 0(0%)
Hypertensive disorders 3(10.3%) 81(36.8%) 1(33.3%)
Obstetric Haemorrhage 11(37.9%) 88(40%) 0(0%)
Pregnancy related infection 4(13.8%) 19(8.6%) 0(0%)
Other obstetric 
complications 2(6.9%) 5(2.3%) 2(66.7%)
Unanticipated complications 
of management 1(3.4%) 1(0.5%) 0(0%)
Indirect
Non obstetric complications 4(13.8%) 17(7.7%) 0(0%)
Coincidental (0%) (0%) (0%)
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29 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and  Gynaecologists, 
Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service Executive
30 Providing equity of critical and maternity care for the critically ill pregnant or recently pregnant woman. Maternal Critical Care 
Working Group. Royal College of Obstetricians and Gynaecologists (2011)
Specialist review during Level 2 Care
Early consultation with anaesthetic staff 
is recommended in cases where there is 
a concern or a high risk of rapid maternal 
deterioration.29 Data on non-obstetric medical 
specialist review was available for 326 of the 
329 cases. Of these 326 cases, the majority 
(n=323, 99.1%) of women were reviewed 
by a non-obstetric medical specialist, most 
commonly (315, 97.5%) by an anaesthetist 
(Figure 8).
Early Pregnancy loss
Early pregnancy loss (pre-viable) was 
associated with a small number of cases 
(n=11, 1.5%, unknown for one case), of which 
most (n=9) were associated with obstetric 
haemorrhage, four of which were major 
obstetric haemorrhage, and a further two 
cases were associated with pregnancy-related 
infection.
Neonatal outcome/care
Fourteen of the 329 women who required Level 
2 Care only experienced perinatal deaths. There 
were seven stillbirths and seven early neonatal 
deaths.
Location of neonatal care during maternal Level 
2 Care
It has been recommended that models of 
critical care should consider nursing mother 
and baby together unless precluded by a 
clinical indication.30 Of the 304 cases where 
a live born infant was delivered, the majority 
(n=201, 66.1%) of infants were not cared for at 
the same location as the mother during Level 
2 Care. Of these, data on the location of care of 
the neonate was available for 197 cases. The 
majority (n=174, 88.3%) were admitted to the 
SCBU/NICU. 
Data on whether admission was required 
for the neonate’s own clinical condition was 
Figure 8: Non obstetric medical specialist review during Level 2 Care, 2015
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recorded for 172 of the 174 infants admitted 
SCBU/NICU. In the majority of cases admission 
was required for the neonate’s own clinical 
condition (n=135; 78.5%). For the 37 (21.5%) 
infants who did not have a clinical indication 
for admission to the SBCU/NICU, the location of 
maternal care was in an ICU for the majority of 
cases (n=25, 67.6%). 
Based on the WHO classification system for 
maternal deaths, over three quarters (77.8%) of 
the women requiring Level 3 Care were classified 
as having a direct obstetric morbidity, four 
(22.2%) were due to indirect causes and there 
were no cases attributed to a coincidental cause 
(Table 24). This is in contrast to national and UK 
data on maternal mortality which has shown 
that a higher proportion of maternal deaths were 
due to indirect obstetric causes compared to 
direct causes.31,32
Table 24 demonstrates the number of maternal 
morbidities identified using the three different 
definitions for maternal morbidity: the NPEC 
SMM, the WHO Near Miss (NM) and the WHO 
Severe Maternal Complication (SMC) criteria. 
In contrast to women requiring Level 2 Care 
only, all of the  maternal morbidity cases 
requiring Level 3 Care satisfied the criteria 
for the NPEC SMM (100%), the WHO Near Miss 
(NM) (100%) and the WHO Severe Maternal 
Complication (SMC) (100.0%). For morbidities 
due to indirect causes, the NPEC SMM and 
WHO Near Miss (NM) definitions identified 
women in need of a higher level of care but no 
cases fulfilled the criteria for the WHO Severe 
Maternal Complication (SMC).
Specific findings for women who required Level 3 Care
Maternal morbidity in women requiring Level 3 Care
31 O’Hare MF, Manning E, Corcoran P, Greene RA on behalf of MDE Ireland. Confidential Maternal Enquiry in Ireland, Data Brief No 2. 
Cork: MDE Ireland, December 2016.
32 Knight M, Tuffnell D, Kenyon S, Shakespeare J, Gray R, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving 
Mothers’ Care - Surveillance of maternal deaths in the UK 2012-2014 and lessons learned to inform maternity care from the UK 
and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2012-2014. Oxford: National Perinatal Epidemiology Unit, 
University of Oxford 2016. Available at: https://www.npeu.ox.ac.uk/mbrrace-uk






All (Direct, Indirect and 
Coincidental) 18(100%) 18(100%) 18(100%) 14(100%)
Direct 14(77.8%) 14(100%) 14(100%) 14(100%)
Pregnancy with abortive 
outcome* 0(0%) 0(0%) 0(0%) 0(0%)
Hypertensive disorders 1(5.6%) 1(100%) 1(100%) 1(100%)
Obstetric Haemorrhage 12(66.7%) 12(100%) 12(100%) 12(100%)
Pregnancy related 




Indirect 4(22.2%) 4(100%) 4(100%) 0(0%)
Non obstetric 
complications 4(22.2%) 4(100%) 4(100%) 0(0%)
Coincidental 0(0%) 0(0%) 0(0%) 0(0%)
Table 24: Classification of maternal morbidity in women who required Level 3 Care in 2015 
according to the NPEC Severe Maternal Morbidity (SMM), WHO Near Miss (NM) and WHO Severe 
Maternal Complication (SMC) criteria
Note: Maternal morbidity definition criteria: NPEC SMM, the WHO Near Miss (NM) and the WHO Severe Maternal Complication 
(SMC) criteria.*Includes complications associated with early pregnancy loss.
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Of the 18 women who required Level 3 Care, 
advanced respiratory support (n=16, 88.9%) 
and basic cardiovascular support (BCVS) 
(n=15, 83.3%) were the most common organ 
support provided (Table 25). Haematological 
support was required for over half of cases 
(n=10, 55.6%).
Location of Level 3 Care 
For women requiring Level 3 Care, ICU was the 
location of care for all of the 18 cases. In these 
18 cases where Level 3 Care was provided in 
an ICU, the ICU facility was on a co-located site 
for the majority of cases (n=14, 77.8%): and 
the remainder (n=4, 22.2%) were cared for in 
an off-site location within the maternity unit’s 
HSE regional network. Information on whether 
there was a delay in accessing the ICU facility 
was known for 17 of the 18 cases. For all 17 
cases there was no delay in accessing the ICU 
facility. 
Communication and specialist review prior to 
Level 3 Care
Communication of critical information is an 
essential component of patient care, safety 
and risk management. A key recommendation 
in national guidelines is the necessity for a 
multidisciplinary care plan in the management 
of the critically ill pregnant woman.33
Information on whether a written 
multidisciplinary care plan accompanied 
the maternal transfer details to Level 3 Care 
was available for 17 of 18 cases. Of these 17 
cases, a written multidisciplinary care plan 
accompanied the maternal transfer details in 
the majority (n=14, 82.4%) of cases.
Of the 18 cases requiring Level 3 Care, it 
was reported that a discussion between the 
obstetric team and the anaesthetist or critical 
care intensivist occurred prior to admission 
for Level 3 Care in the majority of cases (n=11, 
unknown for 6 cases). Almost all (n=16, 94.1%, 
unknown for one case) women were reviewed 
by an anaesthetist or critical care intensivist 
prior to admission for Level 3 Care.
Interdisciplinary communication following 
Level 3 Care
Data on written interdisciplinary communication 
was available for 16 of the 18 Level 3 Care cases. 
For all but one (93.8%) of the 16 cases, a written 
discharge summary of Level 3 Care was received 
by the referring obstetric team. 
Maternal monitoring prior to and during Level 3 
Care
For half (n=8, 50.0%, unknown for 2 cases) of 
the women requiring Level 3 Care, an IMEWS 
was used to monitor the woman prior to 
commencement of Level 3 Care. Of the eight 
(50.0%) cases where an IMEWS was not used 
for maternal monitoring prior to Level 3 Care, it 
was reported that the woman was cared for in a 
Organ support required
Table 25: Organ support required during Level 3 Care, 2015
Organ support required N (%)
Advanced Respiratory Support 16(88.9%)
Basic Cardiovascular support (BCVS) 15(83.3%)




Note: More than one organ support is required in Level 3 Care therefore the percentages sum to more than 100%.
33 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists, 
Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service Executive
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location using another physiological monitoring 
tool (theatre, n=4,  50.0%; HDU, n=1, 12.5%; and 
A&E, n=3, 37.5%).
The use of a specific physiological track and 
trigger tool for maternal monitoring during Level 
3 Care was used in the majority of cases (n=14, 
82.4%, unknown for one case).
Invasive monitoring
Almost all (n=17, 94.4%) women required 
invasive monitoring during Level 3 Care. An 
arterial line was used in the majority of cases 
(n=15, 88.2 %) cases, 82.3% (n=14) required a 
CVP and one case (5.9%) required another form 
of invasive monitoring.
Early Pregnancy loss
Early pregnancy loss (pre-viable) was 
experienced by one of the 18 women who 
required Level 3 Care.
Neonatal outcome/care
Two of the 18 women experienced perinatal 
death. These involved one stillbirth and one 
early neonatal death.
Location of neonatal care during maternal Level 
3 Care 
Of the 15 cases where a live born infant was 
delivered, neonatal care was not provided at the 
same location as the mother during Level 3 Care. 
The majority were admitted to the SCBU/NICU 
(n=14, 93.3%), with one case (6.7%) nursed on 
a postnatal ward.
Of the 14 infants who were admitted to SCBU/
NICU, admission was required for the neonate’s 
own clinical condition in the majority of cases 
(n=8, 57.1%).
Confidential Audit of Critical Care in Obstetrics in Ireland
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Appendix B: National Office of Clinical Audit (NOCA) 
endorsement of the Severe Maternal Morbidity in 
Ireland Annual Report 2015 
 
National Office of Clinical Audit, 4th Floor, 121 St. Stephen’s Green, Dublin 2   Tel: 4028577                          
 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
          20th June 2017 
 
Severe Maternal Morbidity in Ireland, Annual Report 2015 
 
Dear Professor Greene, 
 
I acknowledge receipt of the Severe Maternal Morbidity in Ireland Report 2015 and confirm 
following circulation to the NOCA Governance Board and feedback garnered from our membership, 
we are delighted to endorse this report.  
 
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
 
You and your NPEC colleagues are to be congratulated for the quality of the report and manner in 
which you continue to engage with maternity services to maintain this work.   
 
Please accept this as formal endorsement from the NOCA Governance Board of the Severe Maternal 








Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
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Appendix C: Hospital co-ordinators and  
contributors 2015
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed 
Ms Karen Malocca
Coombe Women and Infants 
University Hospital Dr Zara Fonseca Kelly
Cork University  
Maternity Hospital 
Ms Geraldine Hayes  Prof Richard Greene
University Hospital  
Kerry
Ms Mary Stack Courtney
Letterkenny University  
Hospital
Ms Mary Lynch Ms Evelyn Smith
Mayo University Hospital,  
Castlebar
Ms Diane Brady  
Ms Pauline Corcoran
Dr Hilary Ikele,  
Dr Meabh Ní Bhuinneain
Regional Hospital, Mullingar Ms Marie Corbett
Midland Regional Hospital, 
Portlaoise
Ms Ita Kinsella 
Ms Emma Mullins
National Maternity Hospital Dr Anna Durand O’Connor Dr Mary Higgins
Our Lady of Lourdes Hospital, 
Drogheda
Ms Siobhan Weldon 
Ms Sinead Dow
Portiuncula University Hospital, 
Ballinasloe
Ms Priscilla Neilan  
Rotunda Hospital, Dublin Dr Sharon Cooley
Sligo University Hospital Ms Madeleine Munnelly Dr Heather Langan
South Tipperary General Hospital Ms Siobhan Kavanagh
St Luke’s Hospital, Kilkenny Ms Connie McDonagh 
Ms Fiona Dalton
University Hospital Galway Ms Siobhan Canny, Ms C Greaney 
Ms Y Qualter
University Hospital Waterford Ms Janet Murphy
Wexford General Hospital Ms Helen McLoughlin
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Dr Sharon Cooley, Consultant Obstetrician and Gynaecologist,  
Institute of Obstetrics and Gynaecology Representative
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CONFIDENTIAL AUDIT  
OF 
SEVERE MATERNAL MORBIDITY IN IRELAND   
 
Notification Form:  2015  
 
Hospital Name _____________________________________________________ 
 
Completed by _____________________________________________________ 
(Please print name and staff grade)                            
  
Date of event:       
 
Time of onset of event:  (24 hour clock) 
 
 
Woman’s details  
 
Height at booking   ____________cm 
 
Weight at booking ____________kg 
* NPEC case number   
 
 
BMI    Parity:   + 
                                                                         
(Status prior to delivery) 
Date of delivery:   //Gestation at delivery/pregnancy end     
(or pregnancy end)                                                                                                   (Completed weeks)                                                                                                                                                                                                                                                                                                     
                                            
1. Ethnic group: 
White Irish             Irish Traveller 
Any other White background       Please specify country of origin   _____________________ 
Asian or Asian Irish                       Black or Black Irish 
 Other, including mixed ethnic backgrounds:                    Not recorded        
 
 
Number*:   Age  
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2.a. Did the woman smoke at booking?         Yes please specify quantity _____________ 
No       Not recorded 
2b. Did she give up smoking during pregnancy?  Yes     No       Not recorded N/A 
3. Did the woman drink alcohol at booking?          Yes    .No      Not recorded 
4. Is there documented history of drug abuse or attendance at a drug rehabilitation unit? 
None recorded       Prior to this pregnancy        During this pregnancy   
 
5 Obstetric history: Did the woman have a previous caesarean section      Yes       No 
6. This Pregnancy 
6 a. Was this pregnancy the result of infertility treatment? Yes    No       Unknown 
6 b. If yes please specify method of fertility treatment __________________________________ 
7. Was this an early pregnancy loss?   No Yes: MiscarriageYes: Ectopic pregnancy  
If early pregnancy loss please go to question 10 
 
8 Delivery Details 
8a. Onset of Labour:              Spontaneous          Induced          Never in labour 
8b. Lie of fetus at delivery        Longitudinal              Oblique                   Transverse  
8c. Presentation at delivery             Cephalic             Breech                             Other  
8d. Number of fetuses/babies in this delivery   
 
9. Mode of delivery: 
 Baby 1 Baby 2*  Baby 1 Baby 2* 
i) Spontaneous vaginal  
delivery       
vi) Elective LSCS not 
in labour      
 
              
ii) Assisted vaginal   
breech delivery       
vii) Elective LSCS in 
labour      
 
              
iii) Ventouse vaginal   
delivery       
viii) Emergency LSCS 
not in labour      
 
 
iv) Non-rotational forceps  
vaginal delivery       
ix) Emergency LSCS 
in labour      
 
 
v) Rotational forceps  
vaginal delivery       
x) Classical 
Caesarean Section      
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10. Neonatal Outcome 
Please answer yes or no as applicable  
Baby Outcomes Baby 1 Baby 2 Baby 3 
Birth weight in grams    
Intubation following delivery     
Transferred to SBCU/NICU    
*Early Neonatal Death     
*Late Neonatal Death      
Intrauterine death ≥ 500g and/or ≥ 24 weeks gestation    
*Please refer to reference manual for definitions 
 
11.Maternal Care Details 
11a. Location of Care during clinical event: 
Please tick all that apply 
On the ward                 Delivery Suite         High dependency unit            ICU/CCU  
11 b. Level of Care Required:  
 
Please indicate the highest level of care required during the clinical event: 
 
Level of care  Definition Please tick one box 
Level 0: Normal ward care  Care of low risk pregnant women   
 
Level 1: Additional monitoring or 
intervention, or step down from 
higher level of care 
Patients at risk of their condition 
deteriorating and needing a higher level 
of observation or those recently 
relocated from higher levels of care 
 
Level 2: Single Organ Support**  Patients requiring invasive monitoring/ 
intervention* including support for a 
single failing organ system (excluding 
advanced respiratory support). 
 
Level 3: Advanced respiratory 
support alone, or support of two 
or more organ systems** 
Patients requiring advanced respiratory 
support (mechanical ventilation) alone or 
basic respiratory support along with 
support of at least one additional organ. 
 
* invasive monitoring/intervention includes the use of arterial and CVP lines  




Level 2 examples 
Basic Respiratory Support (BRS): 50% or more oxygen via face-mask to maintain oxygen saturation; Continuous Positive Airway 
Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP) 
Basic Cardiovascular Support (BCVS): Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia; Arterial line used for 
pressure monitoring or sampling; CVP line used for fluid management and CVP monitoring to guide therapy 
Advanced Cardiovascular Support (ACVS): Simultaneous use of at least two intravenous, anti-arrhythmic/anti-hypertensive/vasoactive 
drugs, one of which must be a vasoactive drug; Need to measure and treat cardiac output 
Neurological Support: Magnesium infusion to control seizures / other  
Hepatic Support: Management of acute fulminant hepatic failure, e.g. from HELLP syndrome or acute fatty liver, such that 
transplantation is being considered 
 
Level 3 examples 
Advanced Respiratory Support: Invasive mechanical ventilation 
Support of two or more organ systems: Renal support and BRS; BRS/BCVS and an additional organ supported; Intracranial pressure 
monitoring 
Reference:  Saravanakumar K, Davies L, Lewis M, Cooper GM.. High dependency care in an obstetric setting in the UK. Anaesthesia 
2008:63, 1081–6. 
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Maternal Morbidity Category 
(See page 5 for definitions) 
Please tick all that apply 
1. Major obstetric haemorrhage*  
2. Uterine rupture  
3. Peripartum hysterectomy* 
*please specify indication for peripartum hysterectomy  
4. Eclampsia  
5. Renal or liver dysfunction  
6. Pulmonary oedema  
7. Acute respiratory dysfunction  
8. Pulmonary embolism  
9. Cardiac arrest  
10. Coma  
11. Cerebro-vascular event  
12. Status epilepticus  
13. Septicaemic shock  
14. Anaesthetic problem  
15. ICU/CCU admission* 
*please specify indication for admission 
 
         Duration of ICU care in days/ part days 









16. Other severe morbidity, please specify   
17. Interventional radiology (IR)*                        17a Planned                                                                                                                                                
                                                                                  17b. Unplanned  
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Please notify all categories of Severe Maternal Morbidity, as 
outlined above,  occurring during pregnancy or up to 42 days 










Maternal Morbidity Definitions 
1 Major obstetric haemorrhage 
Estimated blood loss ≥ 2500ml, or transfused 5 or more units of blood 
or received treatment for coagulopathy (Fresh Frozen Plasma; 
Fibrinogen Concentrate Substitution Therapy; Platelets)   
(Also includes ectopic pregnancy meeting these criteria) 
2 Uterine rupture 
A complete separation of the wall of the pregnant uterus, with or 
without expulsion of the fetus, involving rupture of membranes at the 
site of the uterine rupture or extension into uterine muscle separate 
from any previous scar, and endangering the life of the mother or 
fetus. 
Excluded: any asymptomatic palpable or visualised defect (e.g. 
dehiscence noted incidentally at caesarean delivery) 
3 Peripartum hysterectomy Peripartum hysterectomy 
4 Eclampsia Seizure associated with antepartum, intrapartum or postpartum symptoms and signs of pre-eclampsia 
5 Renal or liver dysfunction 
Acute onset of biochemical disturbance, urea >15mmol/l, 
creatinine>400mmol/l, AST/ALT >200u/l 
6 Pulmonary oedema 
Clinically diagnosed pulmonary oedema associated with acute 
breathlessness and O2 saturation <95%, requiring O2, diuretics or 
ventilation 
7 Acute respiratory dysfunction 
Requiring intubation or ventilation for >60 minutes (not including 
duration of general anaesthetic) 
8 Pulmonary embolism 
Increased respiratory rate (>20/min), tachycardia, hypotension. 
Diagnosed as “high” probability on V/Q scan or positive spiral chest 
CT scan. Treated by heparin, thrombolysis or embolectomy 
9 Cardiac arrest No detectable major pulse 
10 Coma Including diabetic coma. Unconscious for >12 hours 
11 Cerebro-vascular event 
Stroke, cerebral/cerebellar haemorrhage or infarction, subarachnoid 
haemorrhage, dural venous sinus thrombosis 
12 Status epilepticus Constant or near constant state of having seizures that last 30mins or more 
13 Septicaemic shock Shock (systolic blood pressure <80) in association with infection. No other cause for decreased blood pressure. Pulse of 120bpm or more 
14 Anaesthetic problem Aspiration, failed intubation, high spinal or epidural anaesthetic 
15 ICU/CCU admission Unit equipped to ventilate adults. Admission for one of the above problems or for any other reason. Includes CCU admissions 
16 Other severe morbidity Other severe morbidity, e.g. amniotic fluid embolism 
17 Interventional radiology Received planned (a) or unplanned (b)  interventional radiology 
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Appendix F: The Robson Ten Group  
Classification System34
Group 1 Nulliparous women with a single cephalic pregnancy, at greater than or equal to 37 weeks gestation 
in spontaneous labour
Group 2 Nulliparous women with a single cephalic pregnancy, at greater than or equal to 37 weeks gestation 
who either had labour induced or were delivered by caesarean section before labour
Group 3 Multiparous women, without a previous uterine scar, with a single cephalic pregnancy at greater 
than or equal 37 weeks in spontaneous labour
Group 4 Multiparous women, without a previous uterine scar, with a single cephalic pregnancy at greater 
than or equal to 37 weeks gestation who either had labour induced or were delivered by caesarean 
section
Group 5 All multiparous women, with at least one previous uterine scar and a single cephalic pregnancy at 
greater than or equal to 37 weeks gestation
Group 6 All nulliparous women with a single breech pregnancy
Group 7 All multiparous women with a single breech pregnancy including, women with previous uterine 
scars
Group 8 All women with multiple pregnancies, including women with previous uterine scars
Group 9 All women with a single pregnancy with a transverse or oblique lie, including women with previous 
uterine scars
Group 10 All women with a single cephalic pregnancy at less than or equal to 36 weeks gestation, including 
women with previous scars
34 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/
S0965539501000122.
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Appendix G: National Guidelines for the critically ill 
woman in obstetrics28
SMM Report 2014 080716.indd   52 08/07/2016   10:20
Appendix G: National Guidelines for the critically ill 
woman in obstetrics35
35 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists, Royal 
College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive  
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Appendix H: NPEC Critical Care Form 2015 – Detailed 






CONFIDENTIAL AUDIT of   
 
 







Detailed Case Assessment Form of Level 2 & Level 3 














Please return completed forms to: 
Edel Manning 
Project manager 
National Perinatal Epidemiology Centre 
Department of Obstetrics and Gynaecology 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
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Rationale for this confidential Audit 
 
As part of the on-going confidential clinical audit on severe maternal morbidity in Ireland, the National Perinatal 
Epidemiology Centre (NPEC) aims to conduct an audit on pregnant or recently pregnant women (this includes women 
in the postpartum period and women following early pregnancy loss) requiring Level 2 and Level 3 Critical Care. 
Please see Table1 on page 8 for definitions. 
 
Objectives of this audit are: 
 
 To identify the number of women requiring Level 2 and Level 3 Care in the Irish maternity services 
 To identify the location where critical care is provided  
 To identify resources and other issues impacting on access to and provision of Level 3 care  
 To evaluate the use of ICU/CCU facilities within the Irish Maternity Services. 
 
Please note obstetric patients who are admitted to ICU will be subject to the Intensive Care National Audit and 
Research Centre, (ICNARC) audit. The NPEC confidential audit on critical care in obstetrics compliments the ICNARC 
audit from an obstetric view point. There is no duplication of data collection. 
 
The NPEC is sincerely grateful for your contribution to this audit 
 
Inclusion criteria for the audit of Critical Care in Obstetrics: 
All pregnant or recently pregnant women (up to and including 42 days following delivery, miscarriage, termination of 
pregnancy or ectopic pregnancy) who require Level 2 or Level 3 Care. 
 
Guidelines for completing notification and case assessment forms  
 Definitions and examples of levels of care are outlined in Table1 on page 8 
 Abbreviations are outlined in Table 2 on page 8  
 Please mark the category box on the top of page 1 indicating Level of critical care provided/sequence of care 
 ‘Not known’ codes should be used as sparingly as possible 
 Please ensure that the NPEC Severe Maternal Morbidity Notification Form is completed (either online 
via the NPEC online database or in hard copy form) along with this form 




Thank you for taking the time to complete this form 
• Section 1 & 2 (questions 1- 17) 
• Ensure Severe Maternal Morbidity 
Notification Form has been completed  
Women requiring 
Level 2 Care only 
• Sections 1 & 3 (questions 1 - 6 and 18 - 33 ) 
• Ensure Severe Maternal Morbidity 
Notification Form has been completed  
 
Women requiring 
Level 3 Care only 
• Sections 1 & 2 & 3 (questions 1 - 33 ) 
• Ensure Severe Maternal Morbidity 
Notification Form has been completed  
 
Women requiring 
Level 2 and Level 3 
Care 
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(Please print name and staff grade) 
 
1. Category of the level of Critical Care required in this clinical event 
If applicable please indicate the sequence of critical care provided in this clinical event: 
Level 2 Care only  
Level 3 Care only  
Level 2 Care followed by Level 3 Care   
Level 3 Care followed by Level 2 Care   
Level 2 Care followed by Level 3 Care 
followed by Level 2 
 
 
2. Date of Clinical Event: // 
          Day Month       Year 
 
3. Time of Event:         :   (24 hour clock)   
 
 
4a. Maternal age: 4b. Parity: (Status prior to delivery)  +   
5. Did this woman have a medical/surgical or psychiatric disorder that pre-existed this pregnancy? 
Yes   No  
If yes, please specify disorder(s) ________________________________________________________ 
6. Was this pregnancy identified as ‘high risk’ during the antenatal period?  Yes    No  
 
Section 2: Level 2 Care 
7. Duration of Level 2 Care in days/ part days:                    Days 
                                                       (e.g.1.5 days) 
 
8. Location where Level 2 Care was provided in this clinical event (Please tick all that apply): 
Ward  (Please specify type, maternity/gynaecology/general)___________________________ 
 
Delivery Suite  Theatre  Dedicated HDU /Maternity Hospital  
 
Dedicated HDU/ General Hospital  ICU   CCU 
 
Other, please specify _____________________________ 
  
NPEC Reference Number:  
 
_________________________ 
(As issued from the online 
database) 
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9. Location of maternal care prior to Level 2 Care  
Home  Ward (Please specify type: maternity/gynaecology/general)___________________ 
Delivery Suite  Theatre  Dedicated HDU/Maternity Hospital   
Dedicated HDU/General Hospital  ICU   CCU  
Other, please specify _____________________________ 
 
Inter-hospital Transfer 
10a. Was this woman transferred from another hospital for Level 2 Care?  
Yes   No  (If no, please go to question 11a)  
*Inter-hospital transfer only:  
10b. Was the referring hospital within your HSE regional hospital network? Yes   No  
10c. Please indicate below all heath care professionals in attendance during transfer (please specify grade):  
Anaesthetist ________________  Obstetrician  _____________________ 
Midwife ________________   Nurse ___________       Other, please specify ___________________ 
11a. Please identify the organ system that required support during Level 2 Care  
(Please refer to page 8 for examples of organ support required in Level 2 Care) 
__________________________________________________________________________________________ 
__________________________________________________________________________________________ 
11b. If a Magnesium Sulphate infusion was transfused, what was the primary indication for the transfusion: 
Maternal: treatment for eclamptic seizure Fetal neuroprotection only 
 
Maternal:  prophylaxis of eclampsia in severe pre-eclampsia 
 
12. Please specify the main clinical diagnosis during Level 2 Care in this clinical event: 
__________________________________________________________________________________________ 
__________________________________________________________________________________________ 
Maternal monitoring prior to commencement of Level 2 Care 
13a. Was an I-MEWS chart used prior to commencement of Level 2 Care?  
Yes   No (please go to question 13d) 
13b. If yes, on average how often were physiological observations recorded?  
        (e.g. every 30 minutes)                        Every                 hours                     minutes 
13c. What was the highest I-MEWS score recorded prior to commencement of Level 2 Care?  
_________________________________________________________________________________________ 
13d. If an I-MEWS chart was not used prior to commencement of Level 2 Care, please indicate why not?  
_________________________________________________________________________________________  
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Maternal monitoring during Level 2 Care:  
14a. Was an I-MEWS chart used during Level 2 Care? Yes   No  
 
14b. Was the patient monitored using another specific physiological track and trigger system/tool? 
Yes   No  (please go to question 14d)  
 
14c. Were patient specific triggers identified using this system/ tool? Yes   No  
 
14d. Was invasive monitoring used?  Yes  No  
(If yes, please tick all that apply) 
CVP line   Arterial line   Other  please specify_______________   
 
Specialist review: 
15. Was the woman reviewed by a non-obstetric medical specialist?   Yes    No  
(If yes, please tick all that apply)  
Anaesthetist  Critical Care Intensivist  Haematologist  General surgeon  
Physician ____________________ Neurosurgeon  Cardiologist   Psychiatrist   
(Please specify speciality) 
 
Neonatal Care: 
16a. Location of neonate during maternal Level 2 Care 
Not applicable/not delivered or early pregnancy loss   With mother  (go to question 17a) 
Not with mother  please specify location _______________________________  
16b If neonatal care was transferred to SBCU/NICU, was SBCU/NICU care required for the neonate’s own 
clinical condition? Yes   No  
 
Discharge from Level 2 Care 
 
17a Please indicate the level of care required at discharge from Level 2 Care: 
Level 0  Level 1  Level 3  
17b Please identify the discharge location of this women following Level 2 Care: 
Ward (Please specify type, maternity/gynaecology/general)____________________ 
Delivery Suite  Theatre  Dedicated HDU Maternity Hospital  
Dedicated HDU General Hospital  ICU   CCU  Maternal Death  
Other, please specify ______________________ 
Please use this space to enter any relevant issues regarding provision of Level 2 Care in this event 
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Section 3: Level 3 Care 
18. Duration of Level 3 care in days/part days (e.g. 1.5 days):                           Days         
19a. Please identify the location where Level 3 Care was provided 
 
ICU   CCU   Other, please specify ______________________ 
19b. Where was the ICU/CCU care facilitated?  
Co-located site Off maternity hospital site/ within the HSE regional network  
Off maternity hospital site/ not within the regional network but within the HSE* In another jurisdiction* 
 
*If applicable, please specify reason for transfer of care outside your unit’s HSE regional network 
_________________________________________________________________________________________ 
20. Was there a delay in accessing an ICU/CCU bed?   Yes  No  
 
If yes, what was the estimated time delay in hours?  
21. Location of care prior to commencement of Level 3 Care:  
Ward  (Please specify type, maternity/gynaecology/general)________________________ 
 
Delivery Suite  Theatre  Dedicated HDU Maternity Hospital  
 
Dedicated HDU General Hospital  ICU   CCU   
 
Other, please specify _____________________________ 
 
22. What was the highest level of care provided prior to commencement of Level 3 Care?  
23a. Was the woman reviewed by an Anaesthetist or Critical Care Intensivist prior to ICU/CCU admission? 
Yes (If yes, please go to question 24a)    No        Unknown  
23b. Was there a discussion between the Obstetric Team and the Anaesthetist or Critical Care Intensivist 
prior to admission? 
Yes   No   Unknown  
Maternal monitoring prior to commencement of Level 3 Care 
24a. Was an I-MEWS chart used prior to commencement of Level 3 Care?  
 
Yes   No  (If no, please go to question 24d) 
24b. If yes, on average how often were physiological observations recorded?  
        (e.g. every 30 minutes)                        Every                   hours                       minutes 
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Maternal monitoring during Level 3 Care 
25a. Was the patient monitored using a specific physiological track and trigger system/tool? 
Yes    No  Unknown 
Invasive monitoring: 
 
25b. Was invasive monitoring used during Level 3 Care?  Yes   No   Unknown  
(If yes, please tick all that apply) 
CVP line   Arterial line   Other  please specify_______________   
 
Communication/ transfer details: 
26. Did a written multidisciplinary care plan accompany the maternal transfer details to location of Level 3 
Care? 
Yes   No   Unknown  
If yes, which of the following were identified in the care plan? 
(Please tick all that apply) 
Consultant Obstetrician Consultant Anaesthetist ICU/CCU Intensivist   Senior Midwife 
Neonatologist     Other, please specify ___________________ 
27. Please indicate all healthcare professionals in attendance during transfer to location of Level 3 Care 
(Please specify grade) 
Anaesthetist ________________ Obstetrician  _____________________ 
Midwife __________________ Other ___________________ 
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30. Please indicate in the Table below any organ dysfunction identified and organ support required both at 
commencement of and during Level 3 Care (Please tick all that apply) 
Organ Dysfunction/Support At 
commencement of 
Level 3 Care 
During 





Basic Respiratory support (Definition page 8)  
    
Advanced respiratory support (mechanical ventilation)       
Neurological Dysfunction/Support: 
Prolonged unconsciousness (lasting ≥ 12 hours)……. 
Coma (including metabolic coma)…………………… 
Stroke…………………………………………………… 
Uncontrollable fits/status epilepticus………………… 
Total paralysis………………………………………….. 
    
    
    
    
    




Use of continuous Cardiac Vasoactive Drugs……... 
Severe hypoperfusion (lactate ≥ 4 mmol/L or severe 
acidosis (PH <7.1)……………………………………… 
    
    
    
    
Renal Dysfunction/Support: 
Oligouria, non-responsive to fluids or diuretics 
    
Dialysis for Acute Renal Failure     
Severe acute azotemia (creatinine ≥ 300 µmol/ml or ≥ 
3.5 mg/dL) 
    
Coagulation/Haematological Dysfunction/Support: 
Disseminated Intravascular Coagulopathy (DIC) ….. 
Severe thrombocytopenia (< 50, 000 platelets/ml)..... 
Transfusion of blood or red cells (≥ 5 units)………… 
    
    
    
Hepatic Dysfunction: 
Jaundice in the presence of pre-eclampsia, eclampsia 
    
Severe Acute Hyperbilirubinemia (bilirubin > 100 µmol 
/L or > 6.0 mg/dL) 
    
Uterine Dysfunction: Uterine haemorrhage or 
infection leading to hysterectomy………………….. 
    
Sepsis or Severe Systemic infection     
Multi Organ Failure     
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Location of neonate during Level 3 Care 
31 a. Location of Neonatal Care: 
Not delivered or early pregnancy loss  (please go to question 32) With mother  (please go to question 32) 
 
Not with mother, please specify location _________________________(please go to 31b) 
 
31b. If neonatal care was transferred to SBCU/NICU, was SBCU/NICU care required for the neonate’s own 
clinical condition? Yes   No  
 
32. Discharge details from Level 3 Care 
 
Please indicate the level of care required at discharge from Level 3 Care?  
Level 0 Care  Level 1 Care   Level 2 Care  Maternal Death  
Where was the discharge destination of this women following Level 3 Care? 
Ward  (Please specify type, maternity/gynaecology/general)________________________ 
 
Delivery Suite  Dedicated HDU Maternity Hospital   Dedicated HDU General Hospital  
 
Maternal Death Other, please specify _____________________________ 
 
33a Was a written discharge summary of Level 3 Care received by the referring Obstetric Team/Unit? 
Yes   (Please answer 33b)  No   Unknown  
33b Please indicate all personnel notified of maternal outcome following Level 3 Care: 
Referring Consultant Obstetrician Consultant Neonatologist   Consultant Anaesthetist 
Critical Care Intensivist Physicianplease specify speciality____________________ 
Senior Midwife General Practitioner  Public Health Nurse  Consultant Psychiatrist 




Thank you for taking the time to complete this form 
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Definitions of Levels of Care 
Table 1: Definitions of Level of Care  
Level of care Definition 
Level 0: Normal ward care  Care of low risk pregnant women  
Level 1: Additional monitoring or intervention, 
or step down from higher level of care 
Patients at risk of their condition deteriorating and needing a 
higher level of observation or those recently relocated from 
higher levels of care 
Level 2: Single Organ Support** Patients requiring invasive monitoring */ intervention including 
support for a single failing organ system (excluding advanced 
respiratory support). 
Level 3: Advanced respiratory support alone, or 
support of two or more organ systems** 
Patients requiring advanced respiratory support (mechanical 
ventilation) alone or basic respiratory support along with 
support of at least one additional organ. 
* Invasive monitoring includes the use of arterial and CVP lines  
 
Examples of Critical Care, Level 2 and Level 3: 
 
Level 2 Care: 
Basic Respiratory Support (BRS): 50% or more oxygen via face-mask to maintain oxygen saturation; Continuous 
Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP) 
Basic Cardiovascular Support (BCVS): Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia; 
Arterial line used for pressure monitoring or sampling; CVP line used for fluid management and CVP monitoring to 
guide therapy 
Advanced Cardiovascular Support (ACVS): Simultaneous use of at least two intravenous, anti-arrhythmic/anti-
hypertensive/vasoactive drugs, one of which must be a vasoactive drug; Need to measure and treat cardiac output 
Neurological Support: Magnesium Sulphate infusion to control seizures / other 
Hepatic Support: Management of acute fulminant hepatic failure, e.g. from HELLP syndrome or acute fatty liver, such 
that transplantation is being considered 
 
Level 3 Care: 
Advanced Respiratory Support: Invasive mechanical ventilation 
Support of two or more organ systems:  Renal support and BRS; 
 BRS/BCVS and an additional organ supported (BRS and BCVS occurring simultaneously during the episode count as 
a single organ support);  
Intracranial pressure monitoring 
References: Saravanakumar K, Davies L, Lewis M, Cooper GM. High dependency care in an obstetric setting in the 
UK. Anaesthesia 2008:63, 1081-6 
 
Table 2: Abbreviations  
Abbreviation  Definition  
CCU Coronary Care Unit  
HDU  High Dependency Unit  
ICU  Intensive Care Unit  
I-MEWS Irish Maternity Early Warning System  
 
If you have questions or difficulties regarding any aspect of the form, please do not hesitate to contact 
Edel Manning at: e.manning@ucc.ie, telephone: (021) 4205042 
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Appendix I: Classification of maternal mortality 
WHO Application of ICD-10
The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM36
Maternal Death Deaths of women while pregnant or within 42 days of the end of the 
pregnancy* from any cause related to or aggravated by the pregnancy or 
its management, but not from accidental or incidental causes
Direct Deaths resulting from obstetric complications of the pregnant state 
(pregnancy, labour and puerperium), from interventions, omissions, 
incorrect treatment or from a chain of events resulting from any of the 
above.
Indirect Deaths resulting from previous existing disease, or disease that 
developed during pregnancy and which was not the result of direct 
obstetric causes, but which was aggravated by the physiological effects 
of pregnancy.
Coincidental Deaths from unrelated causes which happen to occur in pregnancy or the 
puerperium.
*Includes giving birth, ectopic pregnancy, miscarriage or termination of pregnancy.
Direct causes Examples of potential causes of deaths
1. Pregnancies withabortive outcome Abortion, miscarriage, ectopic pregnancy and other conditions leading to 
maternal death and a pregnancy with abortive outcome
2. Hypertensive disorders Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth 
and the puerperium
3. Obstetric Haemorrhage Obstetric diseases or conditions directly associated with haemorrhage
4. Pregnancy related infection Pregnancy-related, infection-based diseases or conditions
5. Other obstetric complications All other direct obstetric conditions not included in groups to 1–4
6. Unanticipated complications of 
management Indirect causes
Severe adverse effects and other unanticipated complications of medical 
and surgical care during pregnancy, childbirth or the puerperium
Indirect causes
7. Non obstetric complications Non-obstetric conditions  
e.g. Cardiac disease, Neurological disease, Infection not as a directresult 
of pregnancy, Other indirect causes
8. Unknown /Undetermined Maternal death during pregnancy, childbirth and the puerperium where 
the underlying cause is unknown or was not determined
9. Coincidental causes Death during pregnancy, childbirth and the puerperium due to external 
causes
36 World Health Organisation The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM 2012 France.
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Appendix J: The WHO organ-dysfunction criteria 
defined as Near Miss37
Severe maternal complication Definition
Cardiovascular dysfunction shock, use of continuous vasoactive drugs, cardiac arrest, cardio-
pulmonary resuscitation, severe hypoperfusion (lactate >5mmol/L or 
>45mg/dL) or severe acidosis (pH<7.1)
Respiratory dysfunction acute cyanosis, gasping, severe tachypnea (respiratory rate>40 bpm), 
severe bradypnea (respiratory rate<6 bpm), severe hypoxemia (P AO2/
FiO2<200 O2 saturation <90% for ≥60m in) or intubation and ventilation 
not related to anaesthesia
Renal dysfunction oliguria non responsive to fluids or diuretics, dialysis for acute renal 
failure or severe acute azotemia (creatinine ≥300umol/ml or ≥3.5 mg/
dL)
Coagulation/haematologic dysfunction failure to form clots, massive transfusion of blood or red cells (≥ 5 
units) or severe acute thrombocytopenia (<50,000 platelets/ ml)
Hepatic dysfunction jaundice in the presence of pre-eclampsia, severe acute 
hyperbilirubinemia (bilirubin>100umol/L or >6.0mg/dL)
Neurologic dysfunction prolonged unconsciousness / coma (lasting >12 hours), stroke, status 
epilepticus / uncontrollable fits or global paral
Uterine dysfunction/hysterectomy haemorrhage or infection leading to hysterectomy
Multiple organ dysfunction
Organ dysfunction in maternal near-miss cases
37 Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health Organization; 2011  
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Appendix K: The WHO classification of severe maternal 
complications38
Severe maternal complication Definition
Severe postpartum haemorrhage Genital bleeding after delivery, with at least one of the following: 
perceived abnormal bleeding (≥ 1000 ml) or any bleeding with 
hypotension or blood transfusion.
Severe pre-eclampsia Persistent systolic blood pressure of 160 mmHg or more or a diastolic 
blood pressure of 110 mm Hg; proteinuria of 5 g or more in 24 hours, 
oliguria of < 400 ml in 24 hours; and HELLP syndrome or pulmonary 
oedema. Excludes eclampsia.
Eclampsia Generalised fits in a patient without a previous history of epilepsy. 
Includes coma in pre eclampsia.
Severe systemic infection or
sepsis
Presence of fever (body temperature > 38 degrees C), a confirmed 
or suspected infection (e.g. chorioamnionitis, septic abortion, 
endometritis, pneumonia), and at least one of the following: heart rate 
> 90, respiratory rate > 20, leukopenia (white blood cells < 4000), 
leucocytosis (white cells > 12 000).
Uterine rupture Rupture of uterus during labour confirmed by laparotomy.
38 Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health Organization; 2011
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